Categolies |
Á¦Ç°¸í |
Catalog |
Æ÷Àå ´ÜÀ§ |
ACE Inhibitors |
Angiotensin Converting Enzyme Inhibitor |
12-1-80 |
5 mg |
| Angiotensin I Converting Enzyme Inhibitor | 12-1-81 | 5 mg |
| Angiotensin I Converting Enzyme Inhibitor | 12-1-84 | 5 mg |
| Angiotensin I Converting Enzyme Inhibitor | 12-1-87 | 5 mg |
| Angiotensin I Converting Enzyme Substrate | 12-1-95 | 5 mg |
| Angiotensin I-Converting Enzyme Substrate | 12-1-18 | 5 mg |
Adipokinetic Hormones | Adipokinetic Hormone (Taa-AKH)(Tabanus atratus) | 60-9-15 | 1 mg |
| Adipokinetic Hormone, AKH, locust | 60-9-18 | 1 mg |
| [Tyr1] Adipokinetic Hormone, locust | 60-9-19 | 1 mg |
| Adipokinetic Hormone | 60-9-20 | 1 mg |
| Adipokinetic Hormone II | 60-9-21 | 1 mg |
| Adipokinetic Hormone II | 60-9-23 | 1 mg |
Adrenocorticotropic Hormones (ACTH) | (D-Lys16)-ACTH (1-24) human, bovine, mouse, ovine, porcine, rabbit, rat | 10-1-13A | 0.5 mg |
| (D-Lys16)-ACTH (1-24) human, bovine, mouse, ovine, porcine, rabbit, rat | 10-1-13B | 1 mg |
| (DSer1)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | 10-1-14A | 0.5 mg |
| (DSer1)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | 10-1-14B | 1 mg |
| (p-Iodo-Phe7)-ACTH (4-10) | 10-1-22A | 1 mg |
| (p-Iodo-Phe7)-ACTH (4-10) | 10-1-22B | 5 mg |
| (Tyr15)-ACTH (7-15) | 10-1-27A | 1 mg |
| (Tyr15)-ACTH (7-15) | 10-1-27B | 5 mg |
| [Met(O)4,DLys8,Phe9] ACTH (4-9), human | 10-1-45A | 1 mg |
| [Met(O)4,DLys8,Phe9] ACTH (4-9), human | 10-1-45B | 5 mg |
| Acetyl-ACTH (1-14) | 10-1-12A | 1 mg |
| Acetyl-ACTH (1-14) | 10-1-12B | 5 mg |
| ACTH (1-10), human | 10-1-34A | 1 mg |
| ACTH (1-10), human | 10-1-34B | 5 mg |
| ACTH (11-24) | 10-1-31A | 1 mg |
| ACTH (11-24) | 10-1-31B | 5 mg |
| ACTH (1-13), human | 10-1-28A | 0.5 mg |
| ACTH (1-13), human | 10-1-28B | 1 mg |
| ACTH (1-14) | 10-1-29A | 1 mg |
| ACTH (1-14) | 10-1-29B | 5 mg |
| ACTH (1-16), human | 10-1-26A | 0.5 mg |
| ACTH (1-16), human | 10-1-26B | 1 mg |
| ACTH (1-17), human | 10-1-58A | 0.5 mg |
| ACTH (1-17), human | 10-1-58B | 1 mg |
| ACTH (12-39), rat | 10-1-16A | 0.5 mg |
| ACTH (12-39), rat | 10-1-16B | 1 mg |
| ACTH (1-24), human | 10-1-21A | 0.5 mg |
| ACTH (1-24), human | 10-1-21B | 1 mg |
| ACTH (1-39), guinea pig | 10-1-17A | 0.5 mg |
| ACTH (1-39), guinea pig | 10-1-17B | 1 mg |
| ACTH (1-39), human | 10-1-10A | 0.5 mg |
| ACTH (1-39), human | 10-1-10B | 1 mg |
| ACTH (1-39), rat | 10-1-15A | 0.5 mg |
| ACTH (1-39), rat | 10-1-15B | 1 mg |
| ACTH (18-39), human | 10-1-32A | 0.5 mg |
| ACTH (18-39), human | 10-1-32B | 1 mg |
| ACTH (22-39) | 10-1-35 | 1 mg |
| ACTH (34-39) | 10-1-38A | 1 mg |
| ACTH (34-39) | 10-1-38B | 5 mg |
| ACTH (4-10), human | 10-1-37A | 1 mg |
| ACTH (4-10), human | 10-1-37B | 5 mg |
| ACTH (4-11), human | 10-1-40A | 1 mg |
| ACTH (4-11), human | 10-1-40B | 5 mg |
| ACTH (4-9) | 10-1-19A | 1 mg |
| ACTH (4-9) | 10-1-19B | 5 mg |
| ACTH (5-10) | 10-1-24A | 1 mg |
| ACTH (5-10) | 10-1-24B | 5 mg |
| ACTH (6-24), human | 10-1-55A | 0.5 mg |
| ACTH (6-24), human | 10-1-55B | 1 mg |
| ACTH (7-38), human | 10-1-30A | 0.5 mg |
| ACTH (7-38), human | 10-1-30B | 1 mg |
| Biotin-ACTH (1-39), Human | 10-1-11A | 0.5 mg |
| Biotin-ACTH (1-39), Human | 10-1-11B | 1 mg |
| Corticostatin, rabbit | 34-7-25 | 10 ug |
| N-Acetyl, ACTH (1-17), human | 10-1-59A | 0.5 mg |
| N-Acetyl, ACTH (1-17), human | 10-1-59B | 1 mg |
| Tyr-ACTH (4-10) | 10-1-23A | 1 mg |
| Tyr-ACTH (4-10) | 10-1-23B | 5 mg |
| Tyr-ACTH (4-9) | 10-1-20A | 1 mg |
| Tyr-ACTH (4-9) | 10-1-20B | 5 mg |
Adrenomedullins | Adrenomedullin (1-12), human | 22-1-08A | 0.5 mg |
| Adrenomedullin (1-12), human | 22-1-08B | 1 mg |
| Adrenomedullin (11-50), rat | 22-8-15A | 0.5 mg |
| Adrenomedullin (11-50), rat | 22-8-15B | 1 mg |
| Adrenomedullin (13-52), human | 22-1-11A | 0.5 mg |
| Adrenomedullin (13-52), human | 22-1-11B | 1 mg |
| Adrenomedullin (1-50), rat | 22-8-10A | 0.5 mg |
| Adrenomedullin (1-50), rat | 22-8-10B | 1 mg |
| Adrenomedullin (1-52), human | 22-2-10A | 0.5 mg |
| Adrenomedullin (1-52), human | 22-2-10B | 1 mg |
| Adrenomedullin (1-52), porcine | 22-3-10A | 0.5 mg |
| Adrenomedullin (1-52), porcine | 22-3-10B | 1 mg |
| Adrenomedullin (16-31), human, pig | 22-1-09A | 0.5 mg |
| Adrenomedullin (16-31), human, pig | 22-1-09B | 1 mg |
| Adrenomedullin (22-52), human | 22-1-16A | 0.5 mg |
| Adrenomedullin (22-52), human | 22-1-16B | 1 mg |
| Pro-Adrenomedullin (153-185), human | 22-2-13A | 10 ug |
| Pro-Adrenomedullin (153-185), human | 22-2-13B | 0.5 mg |
| Pro-Adrenomedullin (45-92), human | 22-2-12 | 10 ug |
| Pro-Adrenomedullin (N-20), human | 22-1-19A | 0.5 mg |
| Pro-Adrenomedullin (N-20), human | 22-1-19B | 1 mg |
| Pro-Adrenomedullin (N-20), porcine | 22-3-11A | 0.5 mg |
| Pro-Adrenomedullin (N-20), porcine | 22-3-11B | 1 mg |
| Pro-Adrenomedullin (N-20), rat | 22-8-20A | 0.5 mg |
| Pro-Adrenomedullin (N-20), rat | 22-8-20B | 1 mg |
| Proadrenomedullin N-terminal 20 Peptide (Human, 9-20) | 22-1-07A | 0.5 mg |
| Proadrenomedullin N-terminal 20 Peptide (Human, 9-20) | 22-1-07B | 1 mg |
Agouti Related Peptides | Agouti-related Protein (AGRP) (25-82), human | 45-1-16A | 0.5 mg |
| Agouti-related Protein (AGRP) (25-82), human | 45-1-16B | 1 mg |
| Agouti-related Protein (AGRP) [Tyr0] (25-51) , human | 45-1-14A | 0.5 mg |
| Agouti-related Protein (AGRP) [Tyr0] (25-51) , human | 45-1-14B | 1 mg |
| Agouti-related Protein (AGRP) [Tyr0] (54-82), human | 45-1-15A | 0.5 mg |
| Agouti-related Protein (AGRP) [Tyr0] (54-82), human | 45-1-15B | 1 mg |
Allatostatins | Allatostatin I | 87-7-10A | 1 mg |
| Allatostatin I | 87-7-10B | 5 mg |
| Allatostatin II | 87-7-20A | 1 mg |
| Allatostatin II | 87-7-20B | 5 mg |
| Allatostatin III | 87-7-30A | 1 mg |
| Allatostatin III | 87-7-30B | 5 mg |
| Allatostatin IV | 87-7-40A | 1 mg |
| Allatostatin IV | 87-7-40B | 5 mg |
Amylins | Amylin (1-13), human | 74-5-12A | 0.5 mg |
| Amylin (1-13), human | 74-5-12B | 1 mg |
| Amylin (8-37), human | 74-5-16A | 0.5 mg |
| Amylin (8-37), human | 74-5-16B | 1 mg |
| Amylin (8-37), rat | 74-5-13A | 0.5 mg |
| Amylin (8-37), rat | 74-5-13B | 1 mg |
| Amylin, human, amide | 74-5-14A | 0.5 mg |
| Amylin, human, amide | 74-5-14B | 1 mg |
| Amylin, human, free acid | 74-5-15A | 0.5 mg |
| Amylin, human, free acid | 74-5-15B | 1 mg |
| Amylin, rat | 74-5-10A | 0.5 mg |
| Amylin, rat | 74-5-10B | 1 mg |
Amyloids & Related Peptides | (Glp3) β -Amyloid (3-42) | 62-0-21A | 0.5 mg |
| (Glp3) β -Amyloid (3-42) | 62-0-21B | 1 mg |
| [Arg13] β -Amyloid (1-40) | 62-0-27A | 0.5 mg |
| [Arg13] β -Amyloid (1-40) | 62-0-27B | 1 mg |
| [Arg22] β -Amyloid (1-40) | 62-0-87A | 0.5 mg |
| [Arg22] β -Amyloid (1-40) | 62-0-87B | 1 mg |
| [Asp22] β -Amyloid (1-40) | 62-0-88A | 0.5 mg |
| [Asp22] β -Amyloid (1-40) | 62-0-88B | 1 mg |
| [Cys] β -Amyloid (1-40) | 62-0-23A | 0.5 mg |
| [Cys] β -Amyloid (1-40) | 62-0-23B | 1 mg |
| [DAsp1]-Amyloid β Protein Fragment(1-42) | 62-1-05A | 0.5 mg |
| [DAsp1]-Amyloid β Protein Fragment (1-42) | 62-1-05B | 1 mg |
| [Des Glu22] Amyloid β (1-42) | 62-1-06A | 0.5 mg |
| [Des Glu22] Amyloid β (1-42) | 62-1-06B | 1 mg |
| [Gln11] β -Amyloid (1-16) | 62-0-70A | 0.5 mg |
| [Gln11] β -Amyloid (1-16) | 62-0-70B | 1 mg |
| [Gln11] β -Amyloid (1-28) | 62-0-75A | 0.5 mg |
| [Gln11] β -Amyloid (1-28) | 62-0-75B | 1 mg |
| [Gln11] β -Amyloid (1-40) | 62-0-79A | 0.5 mg |
| [Gln11] β -Amyloid (1-40) | 62-0-79B | 1 mg |
| [Gln22] β -Amyloid (1-40) | 62-0-89A | 0.5 mg |
| [Gln22] β -Amyloid (1-40) | 62-0-89B | 1 mg |
| [Gly21] β -Amyloid (1-40) | 62-0-61A | 0.5 mg |
| [Gly21] β -Amyloid (1-40) | 62-0-61B | 1 mg |
| [Gly22] β -Amyloid (1-40) | 62-0-24A | 0.5 mg |
| [Gly22] β -Amyloid (1-40) | 62-0-24B | 1 mg |
| [Lys22] β -Amyloid (1-40) | 62-0-91A | 0.5 mg |
| [Lys22] β -Amyloid (1-40) | 62-0-91B | 1 mg |
| [Nle35] β -Amyloid (1-40) | 62-0-26A | 0.5 mg |
| [Nle35] β -Amyloid (1-40) | 62-0-26B | 1 mg |
| [Phe10] β -Amyloid (1-40) | 62-0-25A | 0.5 mg |
| [Phe10] β -Amyloid (1-40) | 62-0-25B | 1 mg |
| Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 62-0-18A | 0.5 mg |
| Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 62-0-18B | 1 mg |
| Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 | 62-0-19A | 0.5 mg |
| Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 | 62-0-19B | 1 mg |
| Amyloid BRI Precursor277 (89-106) | 62-0-02A | 0.5 mg |
| Amyloid BRI Precursor277 (89-106) | 62-0-02B | 1 mg |
| Amyloid Dan Protein (1-34) | 62-0-04A | 0.5 mg |
| Amyloid Dan Protein (1-34) | 62-0-04B | 1 mg |
| Amyloid Precursor C-Terminal Peptide | 62-0-15A | 0.5 mg |
| Amyloid Precursor C-Terminal Peptide | 62-0-15B | 1 mg |
| Amyloid Precursor Frameshift Mutant C-Terminal Peptide | 81-3-10A | 0.5 mg |
| Amyloid Precursor Frameshift Mutant C-Terminal Peptide | 81-3-10B | 1 mg |
| Amyloid Precursor N-Terminal Peptide | 62-0-14A | 0.5 mg |
| Amyloid Precursor N-Terminal Peptide | 62-0-14B | 1 mg |
| β -Amyloid (10-20) | 62-0-20A | 0.5 mg |
| β -Amyloid (10-20) | 62-0-20B | 1 mg |
| β -Amyloid (10-35), amide | 62-0-16A | 0.5 mg |
| β -Amyloid (10-35), amide | 62-0-16B | 1 mg |
| β -Amyloid (1-11) | 62-0-10A | 0.5 mg |
| β -Amyloid (1-11) | 62-0-10B | 1 mg |
| β -Amyloid (1-16), human | 62-0-36A | 0.5 mg |
| β -Amyloid (1-16), human | 62-0-36B | 1 mg |
| β -Amyloid (12-28) | 62-0-73A | 0.5 mg |
| β -Amyloid (12-28) | 62-0-73B | 1 mg |
| β -Amyloid (1-24) | 62-0-11A | 0.5 mg |
| β -Amyloid (1-24) | 62-0-11B | 1 mg |
| β -Amyloid (1-28) | 62-0-74A | 0.5 mg |
| β -Amyloid (1-28) | 62-0-74B | 1 mg |
| β -Amyloid (1-38) | 62-0-76A | 0.5 mg |
| β -Amyloid (1-38) | 62-0-76B | 1 mg |
| β -Amyloid (1-38), mouse, rat | 62-1-00A | 0.5 mg |
| β -Amyloid (1-38), mouse, rat | 62-1-00B | 1 mg |
| β -Amyloid (1-40) | 62-0-78A | 0.5 mg |
| β -Amyloid (1-40) | 62-0-78B | 1 mg |
| β -Amyloid (1-40), amide | 62-0-65A | 0.5 mg |
| β -Amyloid (1-40), amide | 62-0-65B | 1 mg |
| β -Amyloid (1-40), rat | 62-0-86A | 0.5 mg |
| β -Amyloid (1-40), rat | 62-0-86B | 1 mg |
| ©¬-Amyloid (1-40) Scrambled | 62-1-07A | 0.5 mg |
| ©¬-Amyloid (1-40) Scrambled | 62-1-07B | 1 mg |
| β -Amyloid (1-42) | 62-0-80A | 0.5 mg |
| β -Amyloid (1-42) | 62-0-80B | 1 mg |
| β -Amyloid (1-42), FAM - labeled | 62-1-01 | 10 ug |
| β -Amyloid (1-43) | 62-0-83A | 0.5 mg |
| β -Amyloid (1-43) | 62-0-83B | 1 mg |
| β -Amyloid (1-46) | 62-0-59A | 0.5 mg |
| β -Amyloid (1-46) | 62-0-59B | 1 mg |
| β -Amyloid (17-28) | 62-0-13A | 0.5 mg |
| β -Amyloid (17-28) | 62-0-13B | 1 mg |
| β -Amyloid (17-40) | 62-0-85A | 0.5 mg |
| β -Amyloid (17-40) | 62-0-85B | 1 mg |
| β -Amyloid (22-35) | 62-0-35A | 0.5 mg |
| β -Amyloid (22-35) | 62-0-35B | 1 mg |
| β -Amyloid (25-35) | 62-0-72A | 0.5 mg |
| β -Amyloid (25-35) | 62-0-72B | 1 mg |
| β -Amyloid (31-35) | 62-0-31A | 1 mg |
| β -Amyloid (31-35) | 62-0-31B | 5 mg |
| β -Amyloid (32-35) | 62-0-12 | 1 mg |
| β -Amyloid (33-42) | 62-0-22A | 0.5 mg |
| β -Amyloid (33-42) | 62-0-22B | 1 mg |
| β -Amyloid (35-25) | 62-0-33A | 0.5 mg |
| β -Amyloid (35-25) | 62-0-33B | 1 mg |
| β -Amyloid (40-1) | 62-0-77 | 10 ug |
| β -Amyloid (42-1) | 62-0-81 | 10 ug |
| β -Amyloid / A4 Protein Precursor (APP) (96-110), analog | 62-1-15A | 0.5 mg |
| β -Amyloid / A4 Protein Precursor (APP) (96-110), analog | 62-1-15B | 1 mg |
| β -Amyloid / A4 Protein Precusor (APP) (319-335) | 62-5-10A | 0.5 mg |
| β -Amyloid / A4 Protein Precusor (APP) (319-335) | 62-5-10B | 1 mg |
| β -Amyloid BRI Peptide (1-34) | 62-0-92A | 0.5 mg |
| β -Amyloid BRI Peptide (1-34) | 62-0-92B | 1 mg |
| β -Amyloid Peptide (1-42), mouse, rat | 62-0-84A | 0.5 mg |
| β -Amyloid Peptide (1-42), mouse, rat | 62-0-84B | 1 mg |
| β -Amyloid-Protein (10-35) Trifluoroacetate | 62-1-03A | 1 mg |
| β -Amyloid-Protein (10-35) Trifluoroacetate | 62-1-03B | 5 mg |
| β -Amyloid-Protein (1-15) | 62-1-04A | 1 mg |
| β -Amyloid-Protein (1-15) | 62-1-04B | 5 mg |
| β -Amyloid-Protein (6-20) | 62-1-02A | 1 mg |
| β -Amyloid-Protein (6-20) | 62-1-02B | 5 mg |
| β -Sheet Breaker Peptide iAβ 5 | 62-0-06 | 1 mg |
| Biotinyl- β -Amyloid (1-42) | 62-0-51A | 0.5 mg |
| Biotinyl- β -Amyloid (1-42) | 62-0-51B | 1 mg |
| Non-β -Amyloid Component of Alzheimer's Disease (NAC) | 62-5-25 | 10 ug |
| Prion Protein (118-135), human | 62-0-00A | 0.5 mg |
| Prion Protein (118-135), human | 62-0-00B | 1 mg |
Angiotensins | [Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II | 12-1-60A | 5 mg |
| [Asn1, Val5, Asn9] Angiotensin I, salmon | 12-7-25A | 5 mg |
| [Asn1,Val5] Angiotensin II | 12-1-54A | 5 mg |
| [Ile7] Angiotensin III | 12-1-65A | 5 mg |
| [Sar1,Ala8] Angiotensin II | 12-1-43A | 5 mg |
| [Sar1,Val5, Ala8] Angiotensin II | 12-1-45A | 5 mg |
| [Sar1] Angiotensin II | 12-1-50A | 5 mg |
| [Val4] Angiotensin III | 12-1-64A | 5 mg |
| [Val5] Angiotensin I, bovine | 12-1-27A | 5 mg |
| [Val5] Angiotensin II, human | 12-1-41 | 5 mg |
| A-779 | 12-7-26A | 1 mg |
| Angiogenin Fragment (108-122) | 12-0-15A | 1 mg |
| Angiogenin Fragment (108-123) | 12-0-25A | 1 mg |
| Angiotensin AT2 Receptor Agonist | 12-1-88 | 0.5 mg |
| Angiotensin I, human | 12-1-10A | 5 mg |
| Angiotensin I/II (1-7) | 12-1-11A | 1 mg |
| Angiotensin II (1-4), human | 12-1-37A | 5 mg |
| Angiotensin II (3-8), human | 12-1-32A | 5 mg |
| Angiotensin II (4-8), human | 12-1-51A | 5 mg |
| Angiotensin II (5-8), human | 12-1-39A | 5 mg |
| Angiotensin II Antipeptide | 12-1-40A | 5 mg |
| Angiotensin II, flounder | 12-7-23A | 1 mg |
| Angiotensin II, flounder | 12-7-23B | 5 mg |
| Angiotensin II, human | 12-1-34A | 5 mg |
| Angiotensin III Antipeptide | 12-1-63A | 5 mg |
| Angiotensin III, human | 12-1-61A | 5 mg |
| DPro7-angiontensin-(1-7) | 12-7-28 | 1 mg |
| Proangiotensin- 12, rat | 12-7-29 | 0.5 mg |
| Proll, DAla12 Angiotensin (I) | 12-7-30A | 1 mg |
| Proll, DAla12 Angiotensin (I) | 12-7-30B | 5 mg |
Antibiotic Peptides | Ac-SQNY | 72-2-40A | 1 mg |
| Ac-SQNY | 72-2-40B | 5 mg |
| Bactenecin, bovine | 73-3-10A | 1 mg |
| Bactenecin, bovine | 73-3-10B | 5 mg |
| CD36 Peptide P (139-155) | 79-1-10A | 0.5 mg |
| CD36 Peptide P (139-155) | 79-1-10B | 1 mg |
| CD36 Peptide P (93-110) | 79-1-15A | 0.5 mg |
| CD36 Peptide P (93-110) | 79-1-15B | 1 mg |
| Histatin 5 | 72-2-25A | 0.5 mg |
| Histatin 5 | 72-2-25B | 1 mg |
| Immunstimulating Peptide, human | 74-1-25A | 1 mg |
| Immunstimulating Peptide, human | 74-1-25B | 5 mg |
| Indolicidin | 72-2-28A | 0.5 mg |
| Indolicidin | 72-2-28B | 1 mg |
| K-T-K-C-K-F-L-K-K-C | 74-1-26A | 0.5 mg |
| K-T-K-C-K-F-L-K-K-C | 74-1-26B | 1 mg |
| Magainin Spacer Peptide | 87-9-50A | 0.5 mg |
| Magainin Spacer Peptide | 87-9-50B | 1 mg |
| S-I-G-S-L-A-K | 72-2-41A | 1 mg |
| S-I-G-S-L-A-K | 72-2-41B | 5 mg |
Anti-Inflammatory Peptides | Anti-Inflammatory Peptide 1 | 15-2-10 | 1 mg |
| Anti-Inflammatory Peptide 2 | 15-2-12 | 1 mg |
| Anti-Inflammatory Peptide 3 | 15-2-11 | 1 mg |
Antimicrobial Peptides | Acetyl-Adhesin (1025-1044) amide | 72-2-29A | 0.5 mg |
| Acetyl-Adhesin (1025-1044) amide | 72-2-29B | 1 mg |
| Cecropin A (1-8)-Melittin (1-18) amide | 87-9-51A | 0.5 mg |
| Cecropin A (1-8)-Melittin (1-18) amide | 87-9-51B | 1 mg |
| Cecropin A, porcine | 87-9-59A | 0.5 mg |
| Cecropin A, porcine | 87-9-59B | 1 mg |
| Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | 87-9-63A | 0.5 mg |
| Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | 87-9-63B | 1 mg |
| Cecropin B | 87-9-58A | 0.5 mg |
| Cecropin B | 87-9-58B | 1 mg |
| Cecropin B, Free Acid | 87-9-60A | 0.5 mg |
| Cecropin B, Free Acid | 87-9-60B | 1 mg |
| Cecropin P1, porcine | 87-9-61A | 0.5 mg |
| Cecropin P1, porcine | 87-9-61B | 1 mg |
| Dermaseptin | 79-4-15A | 0.5 mg |
| Dermaseptin | 79-4-15B | 1 mg |
| G-V-L-S-N-V-I-G-Y-L-K-K-L-G-T-G-A-L-N-A-V-L-K-Q | 72-2-27A | 0.5 mg |
| G-V-L-S-N-V-I-G-Y-L-K-K-L-G-T-G-A-L-N-A-V-L-K-Q | 72-2-27B | 1 mg |
| Lactoferricin, bovine, (BLFC) | 72-1-31A | 0.5 mg |
| Lactoferricin, bovine, (BLFC) | 72-1-31B | 1 mg |
| LL-37 | 87-9-66A | 0.5 mg |
| LL-37 | 87-9-66B | 1 mg |
| Magainin 2 | 72-2-26A | 0.5 mg |
| Magainin 2 | 72-2-26B | 1 mg |
| Parasin I | 46-4-74A | 0.5 mg |
| Parasin I | 46-4-74B | 1 mg |
Antioxidant Peptides | H-Pro-His-Cys-Lys-Arg-Met-OH | 17-0-02A | 5 mg |
| H-Pro-His-Cys-Lys-Arg-Met-OH | 17-0-02B | 25 mg |
| H-Pro-Phe-Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu-His-Leu-OH | 17-0-01A | 1 mg |
| H-Pro-Phe-Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu-His-Leu-OH | 17-0-01B | 5 mg |
Apelin Peptides | (Ala13)-Apelin 13, human | 12-1-13A | 0.5 mg |
| (Ala13)-Apelin 13, human | 12-1-13B | 1 mg |
| (Glp1)-Apelin-13, human, bovine | 12-1-16A | 0.5 mg |
| (Glp1)-Apelin-13, human, bovine | 12-1-16B | 1 mg |
| Apelin-12, human, bovine, mouse, rat | 12-1-17A | 0.5 mg |
| Apelin-12, human, bovine, mouse, rat | 12-1-17B | 1 mg |
| Apelin-13, human, bovine | 12-1-15A | 0.5 mg |
| Apelin-13, human, bovine | 12-1-15B | 1 mg |
| Apelin-36, human | 12-1-21B | 1 mg |
| Apelin-36, human | 12-1-21A | 0.5 mg |
Apoptosis & Related Peptides | (Asp-Glu-Val-Asp)2-Rhodamine 110 | 81-6-67A | 1 mg |
| (Asp-Glu-Val-Asp)2-Rhodamine 110 | 81-6-67B | 5 mg |
| IL-1 B Converting Enzyme (ICE) Inhibitor IV | 81-7-01A | 1 mg |
| Mca-YVADAPK(Dnp) | 81-7-96A | 0.5 mg |
| Mca-YVADAPK(Dnp) | 81-7-96B | 1 mg |
Atrial Natriuretic Peptides | (Tyr0)-Prepro-Atrial Natriuretic Factor (104-123), human | 14-1-31A | 0.5 mg |
| (Tyr0)-Prepro-Atrial Natriuretic Factor (104-123), human | 14-1-31B | 1 mg |
| [Met(O)12] ANP (1-28), human | 14-1-35A | 0.5 mg |
| [Met(O)12] ANP (1-28), human | 14-1-35B | 1 mg |
| [Tyr0] Atriopeptin II | 14-1-52A | 0.5 mg |
| [Tyr0] Atriopeptin II | 14-1-52B | 1 mg |
| Anantin | 14-1-41A | 0.5 mg |
| Anantin | 14-1-41B | 1 mg |
| ANP (1-11), rat | 14-1-70 | 1 mg |
| ANP (11-30), frog | 14-7-21A | 0.5 mg |
| ANP (11-30), frog | 14-7-21B | 1 mg |
| ANP (3-28), rat | 14-5-44A | 0.5 mg |
| ANP (3-28), rat | 14-5-44B | 1 mg |
| ANP (8-30), frog | 14-7-23A | 0.5 mg |
| ANP (8-30), frog | 14-7-23B | 1 mg |
| ANP(4-23), rat | 14-7-26A | 0.5 mg |
| ANP(4-23), rat | 14-7-26B | 0.5 mg |
| Atrial Natriuretic Factor (1-29), chicken | 14-3-10A | 0.5 mg |
| Atrial Natriuretic Factor (1-29), chicken | 14-3-10B | 1 mg |
| Atrial Natriuretic Peptide (1-28), rat | 14-5-41A | 0.5 mg |
| Atrial Natriuretic Peptide (1-28), rat | 14-5-41B | 1 mg |
| Atrial Natriuretic Peptide (3-28), human | 14-1-18A | 0.5 mg |
| Atrial Natriuretic Peptide (3-28), human | 14-1-18B | 1 mg |
| Atrial Natriuretic Peptide (4-24), frog | 14-7-24A | 0.5 mg |
| Atrial Natriuretic Peptide (4-24), frog | 14-7-24B | 1 mg |
| Atrial Natriuretic Peptide (5-28), human | 14-1-21A | 0.5 mg |
| Atrial Natriuretic Peptide (5-28), human | 14-1-21B | 1 mg |
| Atrial Natriuretic Peptide (ANP)(1-28) Alpha (Human, Ovine, Canine) | 14-5-40A | 0.5 mg |
| Atrial Natriuretic Peptide (ANP)(1-28) Alpha (Human, Ovine, Canine) | 14-5-40B | 1 mg |
| Atrial Natriuretic Polypeptide (4-28), human | 14-1-38A | 0.5 mg |
| Atrial Natriuretic Polypeptide (4-28), human | 14-1-38B | 1 mg |
| Atrial Natriuretic Polypeptide (5-27), human | 14-1-40A | 0.5 mg |
| Atrial Natriuretic Polypeptide (5-27), human | 14-1-40B | 1 mg |
| Atriopeptin I | 14-5-53A | 0.5 mg |
| Atriopeptin I | 14-5-53B | 1 mg |
| Auriculin B | 14-5-47A | 0.5 mg |
| Auriculin B | 14-5-47B | 1 mg |
| Biotin-Atrial Natriuretic Peptide (1-28), human, porcine | 14-1-10A | 0.5 mg |
| Biotin-Atrial Natriuretic Peptide (1-28), human, porcine | 14-1-10B | 1 mg |
| Cardiodilatin (1-16), human | 14-1-25A | 1 mg |
| Cardiodilatin (1-16), human | 14-1-25B | 5 mg |
| Des[Gln18,Ser19,Gly20,22,Leu21] ANP (4-23), amide, rat | 14-1-45A | 0.5 mg |
| Des[Gln18,Ser19,Gly20,22,Leu21] ANP (4-23), amide, rat | 14-1-45B | 1 mg |
| Prepro-ANF (104-116), human | 14-1-28A | 0.5 mg |
| Prepro-ANF (104-116), human | 14-1-28B | 1 mg |
| Prepro-ANF (104-123), human | 14-1-30A | 0.5 mg |
| Prepro-ANF (104-123), human | 14-1-30B | 1 mg |
| Prepro-ANF (26-55), human | 14-1-32A | 0.5 mg |
| Prepro-ANF (26-55), human | 14-1-32B | 1 mg |
| Prepro-ANF (56-92), human | 14-1-33A | 0.5 mg |
| Prepro-ANF (56-92), human | 14-1-33B | 1 mg |
| Urodilatin (95-126) | 14-1-15A | 0.5 mg |
| Urodilatin (95-126) | 14-1-15B | 1 mg |
Bag Cell Peptides | a-Bag Cell Peptide (1-7) | 87-0-94 | 1 mg |
| a-Bag Cell Peptide (1-8) | 87-0-93 | 1 mg |
| a-Bag Cell Peptide (1-9) | 87-0-92 | 1 mg |
| b-Bag Cell Factor | 88-0-95 | 1 mg |
| g-Bag Cell Factor | 88-0-96 | 1 mg |
β -Secretase Substrates | [Ala18] β Amyloid (1-40) | 62-0-71A | 0.5 mg |
| [Ala18] β Amyloid (1-40) | 62-0-71B | 1 mg |
| [Glp11] β Amyloid (11-42) | 62-0-95A | 0.5 mg |
| [Glp11] β Amyloid (11-42) | 62-0-95B | 1 mg |
| β Amyloid (11-40) | 62-0-96A | 0.5 mg |
| β Amyloid (11-40) | 62-0-96B | 1 mg |
| β Amyloid (11-42) | 62-0-97A | 0.5 mg |
| β Amyloid (11-42) | 62-0-97B | 1 mg |
| β Amyloid (1-30) | 62-0-98A | 0.5 mg |
| β Amyloid (1-30) | 62-0-98B | 1 mg |
| β Amyloid (3-40) | 62-0-99A | 0.5 mg |
| β Amyloid (3-40) | 62-0-99B | 1 mg |
| β -Amyloid / A4 Protein Precursor (APP) (328-332) | 62-5-15A | 0.5 mg |
| β -Amyloid / A4 Protein Precursor (APP) (328-332) | 62-5-15B | 1 mg |
| β -Amyloid Precursor Protein (732-751) | 62-5-20A | 0.5 mg |
| β -Amyloid Precursor Protein (732-751) | 62-5-20B | 1 mg |
| Biotinylated β -Amyloid (1-40) | 62-0-69A | 0.5 mg |
| Biotinylated β -Amyloid (1-40) | 62-0-69B | 1 mg |
| FITC labeled β -Amyloid (1-42) | 62-0-82B | 1 mg |
| Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp) | 81-3-32A | 0.5 mg |
| Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp) | 81-3-32B | 1 mg |
Big Endothelin & Analogs | [Tyr123] Prepro Endothelin (110-130), amide, human | 88-1-13A | 0.5 mg |
| [Tyr123] Prepro Endothelin (110-130), amide, human | 88-1-13B | 1 mg |
| Big Endothelin-1 (1-38), human | 88-1-30A | 0.5 mg |
| Big Endothelin-1 (1-38), human | 88-1-30B | 1 mg |
| Big Endothelin-1 (1-39), bovine | 88-3-10A | 0.5 mg |
| Big Endothelin-1 (1-39), bovine | 88-3-10B | 1 mg |
| Big Endothelin-1 (1-39), porcine | 88-4-15A | 0.5 mg |
| Big Endothelin-1 (1-39), porcine | 88-4-15B | 1 mg |
| Big Endothelin-1 (1-39), rat | 88-5-50A | 0.5 mg |
| Big Endothelin-1 (1-39), rat | 88-5-50B | 1 mg |
| Big Endothelin-1 (19-38), human | 88-1-33A | 0.5 mg |
| Big Endothelin-1 (19-38), human | 88-1-33B | 1 mg |
| Big Endothelin-1 (22-38), human | 88-1-31A | 0.5 mg |
| Big Endothelin-1 (22-38), human | 88-1-31B | 1 mg |
| Big Endothelin-1 (22-39), bovine | 88-3-11A | 0.5 mg |
| Big Endothelin-1 (22-39), bovine | 88-3-11B | 1 mg |
| Big Endothelin-1 (22-39), porcine | 88-4-16A | 0.5 mg |
| Big Endothelin-1 (22-39), porcine | 88-4-16B | 1 mg |
| Big Endothelin-1 (22-39), rat | 88-5-51A | 0.5 mg |
| Big Endothelin-1 (22-39), rat | 88-5-51B | 1 mg |
| Big Endothelin-2 (1-37), human | 88-1-40A | 0.5 mg |
| Big Endothelin-2 (1-37), human | 88-1-40B | 1 mg |
| Big Endothelin-2 (22-37), human | 88-1-41A | 0.5 mg |
| Big Endothelin-2 (22-37), human | 88-1-41B | 1 mg |
| Big Endothelin-2 (22-38), human | 88-1-38A | 0.5 mg |
| Big Endothelin-2 (22-38), human | 88-1-38B | 1 mg |
| Big Endothelin-3 (1-41), amide, human | 88-5-17 | 10 ug |
| Big Endothelin-3 (22-41), amide, human | 88-5-16A | 0.5 mg |
| Big Endothelin-3 (22-41), amide, human | 88-5-16B | 1 mg |
Bombesins | (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) | 16-7-27A | 1 mg |
| (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) | 16-7-27B | 5 mg |
| [DPhe12,Leu14] Bombesin | 16-7-25A | 1 mg |
| [DPhe12,Leu14] Bombesin | 16-7-25B | 5 mg |
| [DPhe12] Bombesin | 16-7-24A | 1 mg |
| [DPhe12] Bombesin | 16-7-24B | 5 mg |
| [Lys3] Bombesin | 16-7-12A | 1 mg |
| [Lys3] Bombesin | 16-7-12B | 5 mg |
| [Tyr4,DPhe12] Bombesin | 16-7-26A | 1 mg |
| [Tyr4,DPhe12] Bombesin | 16-7-26B | 5 mg |
| [Tyr4] Bombesin | 16-7-22A | 1 mg |
| [Tyr4] Bombesin | 16-7-22B | 5 mg |
| Bombesin | 16-7-10A | 1 mg |
| Bombesin | 16-7-10B | 5 mg |
| Bombesin (8-14) | 16-7-23 | 5 mg |
| BPP 5a | 16-7-28 | 1 mg |
Bone Gla Proteins | [Tyr38, Phe42,46] Bone Gla Protein | 22-1-61 | 1 mg |
| Bone Gla Protein (45-49) | 22-1-62A | 1 mg |
| Bone Gla Protein (45-49) | 22-1-62B | 5 mg |
| Myelopeptide-2 (MP-2) | 22-1-64A | 0.5 mg |
| Myelopeptide-2 (MP-2) | 22-1-64B | 1 mg |
| Osteocalcin (1-49), human | 22-6-10 | 10 ug |
| Osteocalcin (37-49), human | 22-1-63A | 1 mg |
| Osteocalcin (37-49), human | 22-1-63B | 5 mg |
| Osteocalcin (7-19) (human) | 22-1-66A | 1 mg |
| Osteocalcin (7-19) (human) | 22-1-66B | 5 mg |
| Osteocalcin 30-43 Fragment | 22-1-65A | 1 mg |
| Osteocalcin 30-43 Fragment | 22-1-65B | 5 mg |
Bradykinins | [(pCl)Phe5,8] Bradykinin | 18-1-64A | 1 mg |
| [(pCl)Phe5,8] Bradykinin | 18-1-64B | 5 mg |
| [DPhe7] Bradykinin | 18-1-66 | 1 mg |
| [Ile-Ser0] Bradykinin | 18-1-34 | 5 mg |
| [Lys0] Bradykinin | 18-1-21A | 5 mg |
| [Lys0] Bradykinin | 18-1-21B | 25 mg |
| [Lys0-Ala3] Bradykinin | 18-1-24A | 5 mg |
| [Lys0-Ala3] Bradykinin | 18-1-24B | 25 mg |
| [Lys0-Hyp3] Bradykinin | 18-1-51A | 1 mg |
| [Lys0-Hyp3] Bradykinin | 18-1-51B | 5 mg |
| [Met-Lys0] Bradykinin | 18-1-23A | 5 mg |
| [Met-Lys0] Bradykinin | 18-1-23B | 25 mg |
| [N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin | 18-1-70A | 1 mg |
| [N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin | 18-1-70B | 5 mg |
| [N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin | 18-1-71A | 1 mg |
| [N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin | 18-1-71B | 5 mg |
| [Tyr0] Bradykinin | 18-1-27 | 5 mg |
| [Tyr5] Bradykinin | 18-1-30 | 5 mg |
| [Tyr8] Bradykinin | 18-1-28 | 5 mg |
| 7-Methoxycoumarin-4-acetyl [Ala7-(2,4-Dinitrophenyl)Lys9]-Bradykinin | 18-1-69 | 1 mg |
| B9430 | 18-1-77A | 0.5 mg |
| B9430 | 18-1-77B | 1 mg |
| Blomhotin [Leu3] | 18-1-14A | 0.5 mg |
| Blomhotin [Leu3] | 18-1-14B | 1 mg |
| Bradykinin | 18-1-10 | 10 mg |
| Bradykinin (1-3) | 12-1-90 | 5 mg |
| Bradykinin (1-5) | 18-1-55A | 5 mg |
| Bradykinin (1-5) | 18-1-55B | 25 mg |
| Bradykinin (1-6) | 18-1-56A | 5 mg |
| Bradykinin (1-6) | 18-1-56B | 25 mg |
| Bradykinin (1-7) | 18-1-57A | 5 mg |
| Bradykinin (1-7) | 18-1-57B | 25 mg |
| Bradykinin (2-7) | 18-1-58A | 5 mg |
| Bradykinin (2-7) | 18-1-58B | 25 mg |
| Bradykinin (2-9) | 18-1-59A | 5 mg |
| Bradykinin (2-9) | 18-1-59B | 25 mg |
| Hoe 140 | 18-1-75A | 0.5 mg |
| Hoe 140 | 18-1-75B | 1 mg |
| Lys-(Des-Arg9, Leu8)-Bradykinin | 18-1-11 | 5 mg |
| Lys-[Des-Arg9]-Bradykinin | 18-1-12 | 5 mg |
Brain Natriuretic Peptides (BNP) | [Tyr0] BNP (1-32), human | 14-1-91A | 0.5 mg |
| [Tyr0] BNP (1-32), human | 14-1-91B | 1 mg |
| BNP (1-32), human | 14-1-90A | 0.5 mg |
| BNP (1-32), human | 14-1-90B | 1 mg |
| BNP (1-32), porcine | 14-4-11A | 0.5 mg |
| BNP (1-32), porcine | 14-4-11B | 1 mg |
| BNP (1-32), rat | 14-5-11A | 0.5 mg |
| BNP (1-32), rat | 14-5-11B | 1 mg |
| BNP (1-45), mouse | 14-5-30A | 0.5 mg |
| BNP (1-45), mouse | 14-5-30B | 1 mg |
| BNP (1-45), rat | 14-5-20A | 0.5 mg |
| BNP (1-45), rat | 14-5-20B | 1 mg |
| BNP (7-32), porcine | 14-4-15A | 0.5 mg |
| BNP (7-32), porcine | 14-4-15B | 1 mg |
| Vasonatrin Peptide (1-27) | 14-5-10A | 0.5 mg |
| Vasonatrin Peptide (1-27) | 14-5-10B | 1 mg |
C-Peptides | [Tyr0]-C-Peptide, human | 20-1-12A | 0.5 mg |
| [Tyr0]-C-Peptide, human | 20-1-12B | 1 mg |
| C-Peptide, dog | 20-1-16A | 0.5 mg |
| C-Peptide, dog | 20-1-16B | 1 mg |
| C-Peptide, human | 20-1-11A | 0.5 mg |
| C-Peptide, human | 20-1-11B | 1 mg |
| Proinsulin C-Peptide (55-89), human | 20-1-15A | 0.5 mg |
| Proinsulin C-Peptide (55-89), human | 20-1-15B | 1 mg |
| Tyr-C-Peptide, dog | 20-1-17A | 0.5 mg |
| Tyr-C-Peptide, dog | 20-1-17B | 1 mg |
C-Type Natriuretic Peptides | (Tyr0)-C-Type Natriuretic Peptide (32-53), human, porcine, rat | 14-1-43A | 0.5 mg |
| (Tyr0)-C-Type Natriuretic Peptide (32-53), human, porcine, rat | 14-1-43B | 1 mg |
| C-Type Natriuretic Peptide (32-53), human | 14-1-48A | 0.5 mg |
| C-Type Natriuretic Peptide (32-53), human | 14-1-48B | 1 mg |
| C-Type Natriuretic Peptide (1-53), human | 14-1-42A | 0.5 mg |
| C-Type Natriuretic Peptide (1-53), human | 14-1-42B | 1 mg |
| C-Type Natriuretic Peptide, chicken | 14-6-10A | 0.5 mg |
| C-Type Natriuretic Peptide, chicken | 14-6-10B | 1 mg |
| Prepro-CNP (1-27), rat | 14-6-30A | 0.5 mg |
| Prepro-CNP (1-27), rat | 14-6-30B | 1 mg |
| Prepro-CNP (30-50), porcine, rat | 14-6-20A | 0.5 mg |
| Prepro-CNP (30-50), porcine, rat | 14-6-20B | 1 mg |
Calcitonin & Calcitonin Gene Related Peptides (CGRP) | [Tyr0] Calcitonin Gene Related Peptide (28-37), rat | 22-5-12A | 0.5 mg |
| [Tyr0] Calcitonin Gene Related Peptide (28-37), rat | 22-5-12B | 1 mg |
| [Tyr0] Calcitonin Gene Related Peptide II, human | 22-1-18A | 0.5 mg |
| [Tyr0] Calcitonin Gene Related Peptide II, human | 22-1-18B | 1 mg |
| [Tyr0] Calcitonin Gene Related Peptide, rat | 22-5-11A | 0.5 mg |
| [Tyr0] Calcitonin Gene Related Peptide, rat | 22-5-11B | 1 mg |
| [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | 22-5-14A | 0.5 mg |
| [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | 22-5-14B | 1 mg |
| Calcitonin (1-7), human | 22-2-20A | 0.5 mg |
| Calcitonin (1-7), human | 22-2-20B | 1 mg |
| Calcitonin (8-32), salmon | 22-7-15A | 0.5 mg |
| Calcitonin (8-32), salmon | 22-7-15B | 1 mg |
| Calcitonin C-terminal Adjacent Peptide, rat | 22-5-20A | 0.5 mg |
| Calcitonin C-terminal Adjacent Peptide, rat | 22-5-20B | 1 mg |
| Calcitonin Gene Related Peptide (1-19), human | 22-5-16A | 0.5 mg |
| Calcitonin Gene Related Peptide (1-19), human | 22-5-16B | 1 mg |
| Calcitonin Gene Related Peptide (20-37), human | 22-5-15A | 0.5 mg |
| Calcitonin Gene Related Peptide (20-37), human | 22-5-15B | 1 mg |
| Calcitonin Gene Related Peptide (8-37), human | 22-5-17A | 0.5 mg |
| Calcitonin Gene Related Peptide (8-37), human | 22-5-17B | 1 mg |
| Calcitonin Gene Related Peptide (8-37), rat | 22-5-18A | 0.5 mg |
| Calcitonin Gene Related Peptide (8-37), rat | 22-5-18B | 1 mg |
| Calcitonin Gene Related Peptide II, human | 22-1-14A | 0.5 mg |
| Calcitonin Gene Related Peptide II, human | 22-1-14B | 1 mg |
| Calcitonin Gene Related Peptide II, rat | 22-5-35A | 0.5 mg |
| Calcitonin Gene Related Peptide II, rat | 22-5-35B | 1 mg |
| Calcitonin Gene Related Peptide, chicken | 22-7-10A | 0.5 mg |
| Calcitonin Gene Related Peptide, chicken | 22-7-10B | 1 mg |
| Calcitonin Gene Related Peptide, human | 22-1-12A | 0.5 mg |
| Calcitonin Gene Related Peptide, human | 22-1-12B | 1 mg |
| Calcitonin Gene Related Peptide, rat | 22-5-10A | 0.5 mg |
| Calcitonin Gene Related Peptide, rat | 22-5-10B | 1 mg |
| Calcitonin, chicken | 22-7-12A | 0.5 mg |
| Calcitonin, chicken | 22-7-12B | 1 mg |
| Calcitonin, eel | 22-6-00A | 0.5 mg |
| Calcitonin, eel | 22-6-00B | 1 mg |
| Calcitonin, human | 22-1-10A | 0.5 mg |
| Calcitonin, human | 22-1-10B | 1 mg |
| Calcitonin, porcine | 22-8-00A | 0.5 mg |
| Calcitonin, porcine | 22-8-00B | 1 mg |
| Calcitonin, rat | 22-5-30A | 0.5 mg |
| Calcitonin, rat | 22-5-30B | 1 mg |
| Calcitonin, salmon | 22-7-11A | 0.5 mg |
| Calcitonin, salmon | 22-7-11B | 1 mg |
| Elcatonin | 22-7-13A | 0.5 mg |
| Elcatonin | 22-7-13B | 1 mg |
| Glu20-salmon calcitonin | 22-7-14A | 0.5 mg |
| Glu20-salmon calcitonin | 22-7-14B | 1 mg |
| Katacalcin | 22-0-15A | 0.5 mg |
| Katacalcin | 22-0-15B | 1 mg |
| N-proCT Amino-terminal Procalcitonin | 22-2-30 | 10 ug |
Calpain Inhibitors | Acetyl-Calpastatin (184-210), human | 81-5-18A | 0.5 mg |
| Acetyl-Calpastatin (184-210), human | 81-5-18B | 1 mg |
| Calpain Inhibitor I | 81-5-10 | 5 mg |
| Calpain Inhibitor II | 81-5-30 | 1 mg |
| Calpain Inhibitor III, MDL 28170 | 81-7-07A | 1 mg |
| Calpain Inhibitor III, MDL 28170 | 81-7-07B | 5 mg |
| γ -Secretase Inhibitor I | 81-5-16 | 5 mg |
CARTS | CART (1-39), Human, Rat | 46-2-60A | 10 ug |
| CART (1-39), Human, Rat | 46-2-60B | 0.5 mg |
| CART (55-102), human | 46-2-56A | 10 ug |
| CART (55-102), human | 46-2-56B | 0.5 mg |
| CART (55-102), rat | 46-2-55A | 10 ug |
| CART (55-102), rat | 46-2-55B | 0.5 mg |
| CART (55-76), rat | 46-2-57A | 0.5 mg |
| CART (55-76), rat | 46-2-57B | 1 mg |
| CART (62-102), human, rat | 46-2-59A | 10 ug |
| CART (62-102), human, rat | 46-2-59B | 0.5 mg |
| CART (62-76), rat, human | 46-2-58A | 0.5 mg |
| CART (62-76), rat, human | 46-2-58B | 1 mg |
Casomorphins | [(NMe)Phe3, DPro4] β -Casomorphin (1-4), amide, bovine | 32-3-34A | 1 mg |
| [(NMe)Phe3, DPro4] β -Casomorphin (1-4), amide, bovine | 32-3-34B | 5 mg |
| [DAla2, (pCl)Phe3] β -Casomorphin, amide, bovine | 24-3-34A | 1 mg |
| [DAla2, (pCl)Phe3] β -Casomorphin, amide, bovine | 24-3-34B | 5 mg |
| [DAla2,4,Tyr5] β -Casomorphin (1-5), amide, bovine | 24-1-52A | 5 mg |
| [DAla2,4,Tyr5] β -Casomorphin (1-5), amide, bovine | 24-1-52B | 25 mg |
| [DAla2,DPro4,Tyr5] β -Casomorphin (1-5), amide | 24-1-49A | 5 mg |
| [DAla2,DPro4,Tyr5] β -Casomorphin (1-5), amide | 24-1-49B | 25 mg |
| [DAla2,Hyp4,Tyr5] β -Casomorphin (1-5), amide | 24-1-46A | 5 mg |
| [DAla2,Hyp4,Tyr5] β -Casomorphin (1-5), amide | 24-1-46B | 25 mg |
| [DAla2,Met5] β -Casomorphin (1-5), bovine | 24-3-47 | 1 mg |
| [DAla2,Tyr5] β -Casomorphin (1-5), amide, bovine | 24-1-50A | 5 mg |
| [DAla2,Tyr5] β -Casomorphin (1-5), amide, bovine | 24-1-50B | 25 mg |
| [DAla2] β -Casomorphin (1-3), amide, bovine | 24-1-27A | 5 mg |
| [DAla2] β -Casomorphin (1-3), amide, bovine | 24-1-27B | 25 mg |
| [DAla2] β -Casomorphin (1-4), amide, bovine | 24-3-35 | 1 mg |
| [DAla2] β -Casomorphin (1-5), amide, bovine | 24-3-44 | 1 mg |
| [DAla2] β -Casomorphin (1-5), bovine | 24-3-41 | 1 mg |
| [DAla2] β -Casomorphin (1-6), bovine | 24-3-60 | 1 mg |
| [Des-Tyr1] β -Casomorphin, bovine | 32-3-22A | 1 mg |
| [Des-Tyr1] β -Casomorphin, bovine | 32-3-22B | 5 mg |
| [DPro2] β -Casomorphin (1-4), amide | 32-0-38A | 1 mg |
| [DPro2] β -Casomorphin (1-4), amide | 32-0-38B | 5 mg |
| [DPro2] β -Casomorphin (1-5), amide, bovine | 24-3-54 | 1 mg |
| [DPro4] β -Casomorphin (1-4), amide, bovine | 32-3-37A | 1 mg |
| [DPro4] β -Casomorphin (1-4), amide, bovine | 32-3-37B | 5 mg |
| [Val3]β -Casomorphin (1-4), amide, bovine | 24-3-36 | 1 mg |
| β -Casomorphin (1-3) | 24-1-22A | 5 mg |
| β -Casomorphin (1-3) | 24-1-22B | 25 mg |
| β -Casomorphin (1-3), amide | 24-1-25A | 5 mg |
| β -Casomorphin (1-3), amide | 24-1-25B | 25 mg |
| β -Casomorphin (1-4), amide, bovine | 24-3-30A | 1 mg |
| β -Casomorphin (1-4), amide, bovine | 24-3-30B | 5 mg |
| β -Casomorphin (1-4), bovine | 24-3-28A | 1 mg |
| β -Casomorphin (1-4), bovine | 24-3-28B | 5 mg |
| β -Casomorphin (1-5), amide, bovine | 24-3-40 | 1 mg |
| β -Casomorphin (1-5), bovine | 24-3-37 | 1 mg |
| β -Casomorphin (1-6), bovine | 24-3-56 | 1 mg |
| β -Casomorphin (1-7), bovine | 24-3-10A | 5 mg |
| β -Casomorphin (1-7), bovine | 24-3-10B | 25 mg |
| β -Casomorphin, human | 24-1-11A | 5 mg |
| β -Casomorphin, human | 24-1-11B | 25 mg |
Caspase-1 Substrates/Inhibitors | Ac-VAD-CHO | 81-7-02A | 1 mg |
| Ac-VAD-CHO | 81-7-02B | 5 mg |
| Ac-YVAD-AMC | 81-7-30A | 1 mg |
| Ac-YVAD-AMC | 81-7-30B | 5 mg |
| Ac-YVAD-CHO | 81-7-31A | 1 mg |
| Ac-YVAD-CHO | 81-7-31B | 5 mg |
| Ac-YVAD-pNA | 81-7-34 | 1 mg |
| Ac-YVKD-CMK | 81-7-35A | 0.5 mg |
| Ac-YVKD-CMK | 81-7-35B | 1 mg |
| Biotin-YVAD-CHO | 81-7-36A | 0.5 mg |
| Biotin-YVAD-CHO | 81-7-36B | 1 mg |
| Calpain Inhibitor Peptide | 81-5-40 | 0.5 mg |
| Caspase-1 Inhibitor I, Cell-Permeable | 81-6-36A | 0.5 mg |
| Caspase-1 Inhibitor I, Cell-Permeable | 81-6-36B | 1 mg |
| Caspase-1 Inhibitor V | 81-7-06A | 0.5 mg |
| Caspase-1 Inhibitor V | 81-7-06B | 1 mg |
| Caspase-3 Subtrate Ac-Asp-Asn-Leu-Asp-AMC | 81-6-45 | 0.5 mg |
| Caspase-7 Substrate I, Fluorogenic | 81-7-97A | 0.5 mg |
| Caspase-7 Substrate I, Fluorogenic | 81-7-97B | 1 mg |
| GSK-3Beta Peptide Inhibitor | 81-6-38A | 0.5 mg |
| GSK-3Beta Peptide Inhibitor | 81-6-38B | 1 mg |
| GSK-3Beta Peptide Inhibitor, Cell Permeable | 81-6-39A | 0.5 mg |
| GSK-3Beta Peptide Inhibitor, Cell Permeable | 81-6-39B | 1 mg |
| IL-1b Converting Enzyme (ICE) Inhibitor IV | 81-7-01 | 1 mg |
| TNF-a (71-82), human | 81-1-12A | 0.5 mg |
| TNF-a (71-82), human | 81-1-12B | 1 mg |
| YVAD-CHO | 81-7-38A | 1 mg |
| YVAD-CHO | 81-7-38B | 5 mg |
| Z-Val-Ala-Asp-AMC | 81-7-85 | 1 mg |
Caspase-1/4 Substrates/Inhibitors | ICE Inhibitor III | 81-7-32A | 0.5 mg |
| ICE Inhibitor III | 81-7-32B | 1 mg |
| T3 Peptide / Tumstatin (69-88), human | 13-1-13A | 0.5 mg |
| T3 Peptide / Tumstatin (69-88), human | 13-1-13B | 1 mg |
| T7 Peptide / Tumstatin (74-98) , human | 13-1-14A | 0.5 mg |
| T7 Peptide / Tumstatin (74-98) , human | 13-1-14B | 1 mg |
Caspase-1/4 Substrates/Inhibitors Caspase-3 Substrates/Inhibitors | Ac-Asp-Glu-Val-Asp-AFC | 81-7-79 | 1 mg |
| Ac-DEVD-CHO | 81-6-31A | 1 mg |
| Ac-DEVD-CHO | 81-6-31B | 5 mg |
| Ac-DEVD-CMK | 81-6-32A | 1 mg |
| Ac-DEVD-CMK | 81-6-32B | 5 mg |
| Ac-DEVD-pNA | 81-6-40B | 5 mg |
| Ac-IETD-CHO | 81-3-00A | 1 mg |
| Ac-IETD-CHO | 81-3-00B | 5 mg |
| Ac-VDVAD-CHO | 81-7-75 | 1 mg |
| Apopain Substrate | 81-6-30A | 1 mg |
| Apopain Substrate | 81-6-30B | 5 mg |
| Biotin-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK | 81-6-22A | 0.5 mg |
| Biotin-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK | 81-6-22B | 1 mg |
| Caspase-3 Inhibitor I, Cell-Permeable | 81-6-35A | 0.5 mg |
| Caspase-3 Inhibitor I, Cell-Permeable | 81-6-35B | 1 mg |
| Caspase-3 Precursor Protease Substrates | 81-6-23 | 1 mg |
| Caspase-3 Substrate III, Fluorogenic | 81-7-93A | 0.5 mg |
| Caspase-3 Substrate III, Fluorogenic | 81-7-93B | 1 mg |
| Caspase-3 Substrate V, Fluorogenic | 81-7-95A | 0.5 mg |
| Caspase-3 Substrate V, Fluorogenic | 81-7-95B | 1 mg |
| Z-DEVD-FMK | 81-6-28A | 0.5 mg |
| Z-DEVD-FMK | 81-6-28B | 1 mg |
| Z-Val-Asp-Val-Ala-Asp-AFC | 81-7-77 | 1 mg |
Caspase-3/7 Substrates/Inhibitors | Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 81-6-26A | 0.5 mg |
| Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt | 81-6-26B | 1 mg |
| Z-DEVD-R110 | 81-6-25A | 0.5 mg |
| Z-DEVD-R110 | 81-6-25B | 1 mg |
Caspase-6 Substrates/Inhibitors | Ac-VEID-CHO | 81-7-04A | 1 mg |
| Ac-VEID-CHO | 81-7-04B | 5 mg |
| Z-Val-Glu-Ile-Asp-AFC | 81-9-22 | 1 mg |
Caspase-8 Substrates/Inhibitors | Caspase 8 Substrate 1, chromogenic | 81-7-74A | 1 mg |
| Caspase 8 Substrate 1, chromogenic | 81-7-74B | 5 mg |
| Caspase 8 Substrate 1f, fluorogenic | 81-8-06A | 1 mg |
| Caspase 8 Substrate 1f, fluorogenic | 81-8-06B | 5 mg |
| Caspase-8 Inhibitor | 81-8-05A | 1 mg |
| Caspase-8 Inhibitor | 81-8-05B | 5 mg |
| Caspase-8 Inhibitor I, Cell Permeable | 81-8-00A | 0.5 mg |
| Caspase-8 Inhibitor I, Cell Permeable | 81-8-00B | 1 mg |
Caspase-9 Substrates/Inhibitors | Ac-LEHD-CHO | 81-4-00 | 1 mg |
| Caspase 9 Substrate 1, chromogenic | 81-9-01 | 5 mg |
| Caspase-9 Substrate | 81-9-00A | 1 mg |
| Caspase-9 Substrate | 81-9-00B | 5 mg |
Cathepsins & Related Peptides | Cathepsin Inhibitor III | 81-4-70A | 0.5 mg |
| Cathepsin Inhibitor III | 81-4-70B | 1 mg |
| Cathepsin-L Inhibitor | 32-5-02A | 0.5 mg |
| Cathepsin-L Inhibitor | 32-5-02B | 1 mg |
| Cdk2/Cyclin Inhibitory Peptide I | 32-5-00A | 0.5 mg |
| Cdk2/Cyclin Inhibitory Peptide I | 32-5-00B | 1 mg |
| Cdk2/Cyclin Inhibitory Peptide II | 32-5-01A | 0.5 mg |
| Cdk2/Cyclin Inhibitory Peptide II | 32-5-01B | 1 mg |
Chloromethylketones | Ala-Ala-Phe-chloromethylketone TFA | 81-4-56 | 5 mg |
| Ala-Ala-Pro-Val-chloromethylketone | 81-4-57 | 5 mg |
| Biotinyl-e-aminocaproyl-DPhe-Pro-Arg-chloromethylketone | 81-4-58 | 1 mg |
| Cathepsin G Inhibitor | 81-4-68A | 1 mg |
| Cathepsin G Inhibitor | 81-4-68B | 5 mg |
| DPhe-Phe-Arg-chloromethylketone | 81-4-61 | 1 mg |
| DPhe-Pro-Arg-chloromethylketone | 81-4-60 | 1 mg |
| MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone | 81-4-66 | 1 mg |
| MeOSuc-Ala-Ala-Pro-Val-chloromethylketone | 81-4-67 | 1 mg |
| TPCK | 81-4-50A | 1 mg |
| ZPCK | 81-4-52 | 1 mg |
Cholecystokinins (CCK) | (Thr28,Nle31)-Cholecystokinin-33 (25-33) (sulfated) | 46-1-07A | 0.5 mg |
| (Thr28,Nle31)-Cholecystokinin-33 (25-33) (sulfated) | 46-1-07B | 1 mg |
| Caerulein | 46-1-50A | 0.5 mg |
| Caerulein | 46-1-50B | 1 mg |
| Cholecystokinin (1-21) | 46-1-04A | 0.5 mg |
| Cholecystokinin (1-21) | 46-1-04B | 1 mg |
| Cholecystokinin (26-33), free acid; CCK Octapeptide, non-sulfated | 46-1-36A | 0.5 mg |
| Cholecystokinin (26-33), free acid; CCK Octapeptide, non-sulfated | 46-1-36B | 1 mg |
| Cholecystokinin- 33, human | 46-1-51A | 10 ug |
| Cholecystokinin- 33, human | 46-1-51B | 0.5 mg |
| Cholecystokinin Flanking Peptide, Non-Sulfated | 46-1-42 | 1 mg |
| Cholecystokinin, CCK Octapeptide (26-33) | 46-1-32A | 0.5 mg |
| Cholecystokinin, CCK Octapeptide (26-33) | 46-1-32B | 1 mg |
| Cholecystokinin, CCK (27-33) | 46-1-37A | 0.5 mg |
| Cholecystokinin, CCK (27-33) | 46-1-37B | 1 mg |
| Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | 46-1-33A | 0.5 mg |
| Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | 46-1-33B | 1 mg |
| Cholecystokinin, CCK Tetrapeptide (30-33) | 46-1-40 | 1 mg |
| N-Acetyl Cholecystokinin, CCK (26-30), Sulfated | 46-1-41A | 0.5 mg |
| N-Acetyl Cholecystokinin, CCK (26-30), Sulfated | 46-1-41B | 1 mg |
| N-Acetyl Cholecystokinin, CCK (26-31), Non-Sulfated | 46-1-39A | 0.5 mg |
| N-Acetyl Cholecystokinin, CCK (26-31), Non-Sulfated | 46-1-39B | 1 mg |
| N-Acetyl Cholecystokinin, CCK (26-31), Sulfated | 46-1-38A | 0.5 mg |
| N-Acetyl Cholecystokinin, CCK (26-31), Sulfated | 46-1-38B | 1 mg |
| Prepro CCK Fragment V-9-M | 46-1-45 | 1 mg |
Conotoxins & Other Toxins | α -Conotoxin El, Conus ermineus | 41-0-80 | 10 ug |
| α -Conotoxin GI | 41-0-26A | 0.5 mg |
| α -Conotoxin GI | 41-0-26B | 1 mg |
| α -Conotoxin IMI | 41-0-41A | 0.5 mg |
| α -Conotoxin IMI | 41-0-41B | 1 mg |
| α -Conotoxin MI | 41-0-40A | 0.5 mg |
| α -Conotoxin MI | 41-0-40B | 1 mg |
| α -Conotoxin SI | 41-0-27A | 0.5 mg |
| α -Conotoxin SI | 41-0-27B | 1 mg |
| α -Conotoxin SIA | 41-0-28A | 0.5 mg |
| α -Conotoxin SIA | 41-0-28B | 1 mg |
| Apamin | 41-0-23A | 0.5 mg |
| Apamin | 41-0-23B | 1 mg |
| Iberiotoxin | 41-0-20 | 10 ug |
| Scyllatoxin | 41-0-24A | 10 ug |
| ω -Agatoxin-TK | 41-0-69A | 20 mg |
| ω -Conotoxin GVIA | 41-0-30 | 10 ug |
| ω -Conotoxin MVIIC | 41-0-62 | 10 ug |
Corticotropin Releasing Factors | [Cys21] Corticotropin Releasing Factor, human, rat | 34-1-12A | 0.5 mg |
| [Cys21] CRF, human, rat | 34-1-12B | 1 mg |
| [DPhe12, Nle21,38, Glu30, Lys33] CRF(12-41), human, rat | 34-0-13A | 0.5 mg |
| [DPhe12, Nle21,38, Glu30, Lys33] CRF(12-41), human, rat | 34-0-13B | 1 mg |
| α -Helical Corticotropin Releasing Factor (12-41) | 34-0-16A | 0.5 mg |
| α -Helical Corticotropin Releasing Factor (12-41) | 34-0-16B | 1 mg |
| α -Helical Corticotropin Releasing Factor (9-41) | 34-0-15A | 0.5 mg |
| α -Helical Corticotropin Releasing Factor (9-41) | 34-0-15B | 1 mg |
| Antisauvagine-30 | 34-7-12A | 0.5 mg |
| Antisauvagine-30 | 34-7-12B | 1 mg |
| Astressin | 34-0-14A | 0.5 mg |
| Astressin | 34-0-14B | 1 mg |
| Astressin2-B | 34-0-17A | 0.5 mg |
| Astressin2-B | 34-0-17B | 1 mg |
| Corticotropin Releasing Factor, bovine | 34-3-11A | 0.5 mg |
| Corticotropin Releasing Factor, bovine | 34-3-11B | 1 mg |
| Corticotropin Releasing Factor, human, rat | 34-1-10A | 0.5 mg |
| Corticotropin Releasing Factor, human, rat | 34-1-10B | 1 mg |
| Corticotropin Releasing Factor, ovine | 34-2-11A | 0.5 mg |
| Corticotropin Releasing Factor, ovine | 34-2-11B | 1 mg |
| Corticotropin Releasing Factor, porcine | 34-4-11A | 0.5 mg |
| Corticotropin Releasing Factor, porcine | 34-4-11B | 1 mg |
| Eosinophilotactic Peptide | 40-0-01 | 5 mg |
| Eosinophilotactic Peptide | 40-0-64 | 5 mg |
| Prepro Corticotropin Releasing Factor (125-151), human | 34-1-27A | 0.5 mg |
| Prepro Corticotropin Releasing Factor (125-151), human | 34-1-27B | 1 mg |
| Sauvagine, frog | 34-7-11A | 0.5 mg |
| Sauvagine, frog | 34-7-11B | 1 mg |
Cortistatins | Cortistatin 14 | 34-7-31A | 0.5 mg |
| Cortistatin 14 | 34-7-31B | 1 mg |
| Cortistatin 29 (1-13), rat | 34-7-32A | 0.5 mg |
| Cortistatin 29 (1-13), rat | 34-7-32B | 1 mg |
| Cortistatin 29, rat | 34-7-30A | 0.5 mg |
| Cortistatin 29, rat | 34-7-30B | 1 mg |
| Pro-Cortistatin (28-47) | 34-7-33A | 0.5 mg |
| Pro-Cortistatin (28-47) | 34-7-33B | 1 mg |
| Pro-Cortistatin (51-81) | 34-7-34A | 0.5 mg |
| Pro-Cortistatin (51-81) | 34-7-34B | 1 mg |
Dynorphins | [(NMe)Tyr1] Dynorphin A (1-13), amide, porcine | 26-4-54 | 1 mg |
| [DAla2, DArg6] Dynorphin A, (1-13), porcine | 26-4-91 | 5 mg |
| [DAla2] Dynorphin A (1-13), amide, porcine | 26-4-52 | 1 mg |
| [DAla2] Dynorphin A (1-9), porcine | 26-4-81A | 1 mg |
| [DAla2] Dynorphin A (1-9), porcine | 26-4-81B | 5 mg |
| [DArg6] Dynorphin A (1-13), porcine | 26-4-80A | 1 mg |
| [DArg6] Dynorphin A (1-13), porcine | 26-4-80B | 5 mg |
| [DArg8] Dynorphin A (1-13), porcine | 26-4-94 | 5 mg |
| [Des-Tyr1] Dynorphin A (1-8) | 26-4-69 | 1 mg |
| [DPro10] Dynorphin A (1-11), porcine | 26-4-85A | 1 mg |
| [DPro10] Dynorphin A (1-11), porcine | 26-4-85B | 5 mg |
| [Phe7] Dynorphin A (1-7), amide, porcine | 26-4-97A | 0.5 mg |
| [Phe7] Dynorphin A (1-7), amide, porcine | 26-4-97B | 1 mg |
| [Phe7] Dynorphin A (1-7), porcine | 26-4-88A | 0.5 mg |
| [Phe7] Dynorphin A (1-7), porcine | 26-4-88B | 1 mg |
| Dynorphin (2-17), amide, porcine | 26-4-22 | 1 mg |
| Dynorphin A (1-17), (Prodynorphin 209-225), Porcine | 26-4-12A | 1 mg |
| Dynorphin A (1-10), amide, porcine | 26-4-63 | 1 mg |
| Dynorphin A (1-10), porcine | 26-4-62 | 1 mg |
| Dynorphin A (1-11), porcine | 26-4-58 | 1 mg |
| Dynorphin A (1-12), porcine | 26-4-57 | 1 mg |
| Dynorphin A (1-13), amide, porcine | 26-4-51A | 1 mg |
| Dynorphin A (1-13), amide, porcine | 26-4-51B | 5 mg |
| Dynorphin A (1-13), porcine | 26-4-50A | 1 mg |
| Dynorphin A (1-13), porcine | 26-4-50B | 5 mg |
| Dynorphin A (13-17), porcine | 26-4-48A | 1 mg |
| Dynorphin A (13-17), porcine | 26-4-48B | 5 mg |
| Dynorphin A (1-6), porcine | 26-4-75A | 1 mg |
| Dynorphin A (1-6), porcine | 26-4-75B | 5 mg |
| Dynorphin A (1-7), porcine | 26-4-74A | 1 mg |
| Dynorphin A (1-7), porcine | 26-4-74B | 5 mg |
| Dynorphin A (1-8), porcine | 26-4-67 | 1 mg |
| Dynorphin A (1-9), porcine | 26-4-65 | 1 mg |
| Dynorphin A (2-12), porcine | 26-4-55 | 1 mg |
| Dynorphin A (2-17), porcine | 26-4-26 | 1 mg |
| Dynorphin A (3-13), porcine | 26-4-56 | 1 mg |
| Dynorphin A (3-17), porcine | 26-4-27 | 1 mg |
| Dynorphin A (3-8), porcine | 26-4-71 | 1 mg |
| Dynorphin A (6-17), porcine | 26-4-30 | 1 mg |
| Dynorphin A (7-17), porcine | 26-4-31 | 1 mg |
| Dynorphin A (8-17), porcine | 26-4-32 | 1 mg |
| Dynorphin A (9-17), porcine | 26-4-46 | 1 mg |
| Dynorphin A amide, porcine | 26-4-21 | 1 mg |
| Dynorphin B (1-9) | 26-4-38 | 1 mg |
| E-2078 | 26-4-49A | 0.5 mg |
| E-2078 | 26-4-49B | 1 mg |
| Prodynorphin (228-240), porcine | 26-4-35 | 1 mg |
| Prodynorphin (228-256), porcine | 26-4-41A | 0.5 mg |
| Prodynorphin (228-256), porcine | 26-4-41B | 1 mg |
Endomorphins | Endomorphin-1 | 23-1-10A | 5 mg |
| Endomorphin-1 | 23-1-10B | 25 mg |
| Endomorphin-2 | 23-1-12A | 5 mg |
| Endomorphin-2 | 23-1-12B | 25 mg |
Endorphins | [Arg8] a-Neo-Endorphin (1-8) | 28-4-21 | 1 mg |
| [DAla2] a-Neo-Endorphin (1-2), amide | 30-0-42 | 1 mg |
| [DAla2] b-Lipotropin (61-69) | 28-0-26A | 1 mg |
| [DAla2] b-Lipotropin (61-69) | 28-0-26B | 5 mg |
| [DAla2] g-Endorphin | 28-0-45 | 1 mg |
| [Des-Tyr1] b-Endorphin, human | 28-1-30 | 1 mg |
| [Des-Tyr1] g-Endorphin | 28-0-43 | 1 mg |
| [Met5, Lys6, Arg7] a-Neo-Endorphin (1-7) | 30-0-56A | 1 mg |
| [Met5, Lys6, Arg7] a-Neo-Endorphin (1-7) | 30-0-56B | 5 mg |
| [Met5, Lys6,7] a-Neo-Endorphin (1-7) | 30-0-55A | 1 mg |
| [Met5, Lys6,7] a-Neo-Endorphin (1-7) | 30-0-55B | 5 mg |
| [Met5, Lys6] a-Neo-Endorphin (1-6) | 30-0-44A | 1 mg |
| [Met5, Lys6] a-Neo-Endorphin (1-6) | 30-0-44B | 5 mg |
| Ac, β -Endorphin (1-27), camel, bovine, ovine | 28-6-29 | 1 mg |
| Acetyl, a-Endorphin | 28-4-31 | 1 mg |
| Acetyl, β -Endorphin (1-26), human | 28-1-36 | 1 mg |
| Acetyl, β -Endorphin (1-27), human | 28-1-35 | 1 mg |
| Acetyl, β -Endorphin, camel, bovine, ovine | 28-6-23 | 1 mg |
| Acetyl, β -Endorphin, human | 28-1-14 | 1 mg |
| Acetyl, g-Endorphin | 28-0-41 | 1 mg |
| a-Endorphin | 24-4-30 | 1 mg |
| a-Neo-Endorphin (1-7) | 30-0-75A | 1 mg |
| a-Neo-Endorphin (1-7) | 30-0-75B | 5 mg |
| a-Neo-Endorphin Analog | 28-4-24 | 1 mg |
| a-Neo-Endorphin, porcine | 28-4-22 | 1 mg |
| β -Endorphin (1-26), human | 28-1-16 | 1 mg |
| β -Endorphin (1-27), camel, bovine, ovine | 28-6-28 | 1 mg |
| β -Endorphin (1-27), human | 28-1-15 | 1 mg |
| β -Endorphin (1-5) + (16-31), human | 28-1-80 | 1 mg |
| β -Endorphin (6-31), human | 28-1-32 | 1 mg |
| β -Endorphin, camel | 28-6-10 | 1 mg |
| β -Endorphin, human | 28-1-10 | 1 mg |
| β -Endorphin, porcine | 28-4-10 | 1 mg |
| β -Endorphin, rat | 28-5-10 | 1 mg |
| β -Lipotropin (1-10), porcine | 30-0-83 | 1 mg |
| β -Lipotropin (61-64) | 28-0-22 | 5 mg |
| β -Lipotropin (61-69) | 28-0-25 | 1 mg |
| β -Lipotropin (88-91) | 28-0-29 | 5 mg |
| b-Neo-Endorphin | 28-4-26 | 1 mg |
| g-Endorphin | 28-4-40 | 1 mg |
Endostatins | Endostatin (84-114)-NH2 (JKC367) | 13-0-02A | 0.5 mg |
| Endostatin (84-114)-NH2 (JKC367) | 13-0-02B | 1 mg |
Endothelin Converting Enzyme (ECE) Inhibitors & Analogs | [DVal22, Phe33] Big Endothelin-1 (16-38), human | 88-1-34A | 0.5 mg |
| [DVal22, Phe33] Big Endothelin-1 (16-38), human | 88-1-34B | 1 mg |
| [DVal22] Big Endothelin-1 (16-38), human | 88-1-35A | 0.5 mg |
| [DVal22] Big Endothelin-1 (16-38), human | 88-1-35B | 1 mg |
| [Phe22] Big Endothelin-1 (19-37), human | 88-1-36A | 0.5 mg |
| [Phe22] Big Endothelin-1 (19-37), human | 88-1-36B | 1 mg |
| Phosphoramidon | 88-1-37A | 0.5 mg |
| Phosphoramidon | 88-1-37B | 1 mg |
Endothelin Receptor Antagonists | Ac-[DTrp16] Endothelin-1 (16-21), human | 88-2-44A | 0.5 mg |
| Ac-[DTrp16] Endothelin-1 (16-21), human | 88-2-44B | 1 mg |
| Ac-Endothelin-1 (16-21), human | 88-2-34A | 0.5 mg |
| Ac-Endothelin-1 (16-21), human | 88-2-34B | 1 mg |
| PD 142893 | 88-2-43A | 0.5 mg |
| PD 142893 | 88-2-43B | 1 mg |
| PD-145065 | 88-2-33A | 0.5 mg |
| PD-145065 | 88-2-33B | 1 mg |
Endothelin-1 & Analogs | Endothelin-1 (1-15), amide, human | 88-2-38A | 0.5 mg |
| Endothelin-1 (1-15), amide, human | 88-2-38B | 1 mg |
| Endothelin-1 (1-15), human | 88-2-35A | 0.5 mg |
| Endothelin-1 (1-15), human | 88-2-35B | 1 mg |
| Endothelin-1, human | 88-1-10A | 0.5 mg |
| Endothelin-1, human | 88-1-10B | 1 mg |
Endothelin-2, Endothelin-3 & Analogs | Endothelin-2, human | 88-1-20A | 0.5 mg |
| Endothelin-2, human | 88-1-20B | 1 mg |
| Endothelin-3, human | 88-5-10A | 0.5 mg |
| Endothelin-3, human | 88-5-10B | 1 mg |
Enkephalins | [Ala2] Met-Enkephalin, amide | 30-0-27 | 5 mg |
| [Arg0] Met-Enkephalin | 30-0-26A | 1 mg |
| [Arg0] Met-Enkephalin | 30-0-26B | 5 mg |
| [DAla2,DLeu5] Enkephalin | 30-0-71 | 5 mg |
| [DAla2,DMet5] Enkephalin | 30-0-25 | 5 mg |
| [DAla2,Leu5,Arg6] Enkephalin | 30-0-70A | 1 mg |
| [DAla2,Leu5,Arg6] Enkephalin | 30-0-70B | 5 mg |
| [DAla2] Leu-Enkephalin | 30-0-69 | 5 mg |
| [DAla2] Leu-Enkephalin, amide | 30-0-68 | 5 mg |
| [DAla2] Met-Enkephalin | 30-0-21 | 5 mg |
| [DAla2] Met-Enkephalin, amide | 30-0-24 | 5 mg |
| [Des-Tyr1,DAla2] Met-Enkephalin, amide | 30-0-40 | 5 mg |
| [Des-Tyr1,DPen2,5] Enkephalin | 30-0-78A | 1 mg |
| [Des-Tyr1,DPen2,5] Enkephalin | 30-0-78B | 5 mg |
| [Des-Tyr1,DPen2,Pen5] Enkephalin | 30-0-79 | 1 mg |
| [Des-Tyr1] Leu-Enkephalin | 30-0-73 | 25 mg |
| [Des-Tyr1] Met-Enkephalin | 30-0-36 | 5 mg |
| [DMet2,Pro5] Enkephalin, amide | 30-0-32A | 1 mg |
| [DMet2,Pro5] Enkephalin, amide | 30-0-32B | 5 mg |
| [DPen2, Pen5] Enkephalin | 30-0-77A | 1 mg |
| [DPen2, Pen5] Enkephalin | 30-0-77B | 5 mg |
| [DPhe2,5,(pCl)Phe4] Enkephalin | 30-0-81A | 1 mg |
| [DPhe2,5,(pCl)Phe4] Enkephalin | 30-0-81B | 5 mg |
| [DSer2] Leu-Enkephalin-Thr | 30-0-64A | 1 mg |
| [DSer2] Leu-Enkephalin-Thr | 30-0-64B | 5 mg |
| [DThr2] Leu-Enkephalin-Thr | 30-0-66A | 1 mg |
| [DThr2] Leu-Enkephalin-Thr | 30-0-66B | 5 mg |
| [DTrp2] Met-Enkephalin, amide | 30-0-30A | 1 mg |
| [DTrp2] Met-Enkephalin, amide | 30-0-30B | 5 mg |
| [Lys6] Leu-Enkephalin | 30-0-74A | 1 mg |
| [Lys6] Leu-Enkephalin | 30-0-74B | 5 mg |
| [Met5,Arg6,7,Val8,Gly9] Enkephalin | 30-1-31 | 5 mg |
| [Met5,Arg6,Gly7,Leu8] Enkephalin | 30-1-33 | 5 mg |
| [Met5,Arg6,Phe7] Enkephalin | 30-1-34 | 5 mg |
| [Met5,Arg6,Phe7] Enkephalin, amide | 30-1-37 | 5 mg |
| [Met5,Arg6] Enkephalin | 30-1-27 | 5 mg |
| [Met5,Arg6] Enkephalin-Arg | 30-0-46 | 1 mg |
| Adrenorphin, Free Acid | 30-0-51A | 1 mg |
| Adrenorphin, Free Acid | 30-0-51B | 5 mg |
| Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 30-0-72A | 1 mg |
| Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 30-0-72B | 5 mg |
| Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 30-0-34A | 1 mg |
| Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 30-0-34B | 5 mg |
| Benzoyl-Phe-Ala-Arg | 32-0-81A | 1 mg |
| Benzoyl-Phe-Ala-Arg | 32-0-81B | 5 mg |
| Dermenkephalin | 30-1-40A | 1 mg |
| Dermenkephalin | 30-1-40B | 5 mg |
| DPDPE | 30-0-76A | 1 mg |
| DPDPE | 30-0-76B | 5 mg |
| Enkephalinase Substrate | 32-0-80A | 1 mg |
| Enkephalinase Substrate | 32-0-80B | 5 mg |
| Enkephalins | 30-0-40A | 5 mg |
| Leu-Enkephalin | 30-0-60 | 25 mg |
| Leu-Enkephalin, amide | 30-0-80 | 5 mg |
| Met-Enkephalin | 30-0-10 | 5 mg |
| Met-Enkephalin, amide | 30-0-22 | 10 mg |
| Preproenkephalin B (186-204), human | 26-1-12 | 1 mg |
| Spinorphin, bovine | 30-0-85 | 1 mg |
ETA Receptor Antagonists | BE-18257A / [W-7338A] | 88-2-40A | 0.5 mg |
| BE-18257A / [W-7338A] | 88-2-40B | 1 mg |
| BE18257B | 88-2-20A | 0.5 mg |
| BE18257B | 88-2-20B | 1 mg |
| BQ-123 | 88-2-10A | 0.5 mg |
| BQ-123 | 88-2-10B | 1 mg |
| BQ-610 | 88-2-32A | 0.5 mg |
| BQ-610 | 88-2-32B | 1 mg |
| JKC-301 | 88-2-30A | 0.5 mg |
| JKC-301 | 88-2-30B | 1 mg |
| JKC-302 | 88-2-31A | 0.5 mg |
| JKC-302 | 88-2-31B | 1 mg |
ETB Receptor Agonist & Antagonists | [Ala1,3,11,15] Endothelin-1, human | 88-1-11A | 0.5 mg |
| [Ala1,3,11,15] Endothelin-1, human | 88-1-11B | 1 mg |
| BQ-3020 | 88-2-42A | 0.5 mg |
| BQ-3020 | 88-2-42B | 1 mg |
| BQ-788 | 88-2-55A | 0.5 mg |
| BQ-788 | 88-2-55B | 1 mg |
| IRL-1038 | 88-2-41A | 0.5 mg |
| IRL-1038 | 88-2-41B | 1 mg |
| IRL-1620 | 88-2-50A | 0.5 mg |
| IRL-1620 | 88-2-50B | 1 mg |
| IRL-1720 | 88-2-53A | 0.5 mg |
| IRL-1720 | 88-2-53B | 1 mg |
| RES-701-1 | 88-2-51A | 0.5 mg |
| RES-701-1 | 88-2-51B | 1 mg |
| RES-701-3 | 88-2-52A | 0.5 mg |
| RES-701-3 | 88-2-52B | 1 mg |
| Vasoactive Intestinal Contractor [VIC] | 88-1-15A | 0.5 mg |
| Vasoactive Intestinal Contractor [VIC] | 88-1-15B | 1 mg |
Exendins | Des His1, Glu8 Exendin-4 | 46-3-13A | 0.5 mg |
| Des His1, Glu8 Exendin-4 | 46-3-13B | 1 mg |
| Exendin (9-39) | 46-3-10A | 0.5 mg |
| Exendin (9-39) | 46-3-10B | 1 mg |
| Exendin-3 | 46-3-14A | 0.5 mg |
| Exendin-3 | 46-3-14B | 1 mg |
| Exendin-4 | 46-3-12A | 0.5 mg |
| Exendin-4 | 46-3-12B | 1 mg |
| Exendin-4 (3-39) | 46-3-05A | 0.5 mg |
| Exendin-4 (3-39) | 46-3-05B | 1 mg |
Fibronectin and Extra Cellular Matrix Related Peptides | (NMe)G-R-G-D-S-P | 44-0-35 | 1 mg |
| [Glu1] Fibrinopeptide B, human | 42-1-24A | 1 mg |
| [Glu1] Fibrinopeptide B, human | 42-1-24B | 5 mg |
| [Tyr0] Fibrinopeptide A, human | 42-1-16A | 1 mg |
| [Tyr0] Fibrinopeptide A, human | 42-1-16B | 5 mg |
| [Tyr15] Fibrinopeptide B, human | 42-1-27A | 1 mg |
| [Tyr15] Fibrinopeptide B, human | 42-1-27B | 5 mg |
| A-G-D-V | 44-0-11 | 5 mg |
| c(Arg-Gly-Asp-DPhe-Val) | 44-0-53 | 0.5 mg |
| Collagen Binding Fragment | 44-0-20 | 1 mg |
| E-I-L-D-V, human, bovine, rat | 44-0-41 | 1 mg |
| E-I-L-E-V-P-S-T | 44-0-44A | 1 mg |
| E-I-L-E-V-P-S-T | 44-0-44B | 5 mg |
| Fibrinogen β -Chain (24-42) | 42-1-33A | 1 mg |
| Fibrinogen β -Chain (24-42) | 42-1-33B | 5 mg |
| Fibrinogen Binding Inhibitor Peptide | 42-1-40A | 1 mg |
| Fibrinogen Binding Inhibitor Peptide | 42-1-40B | 5 mg |
| Fibrinogen Related Peptide | 42-1-31A | 1 mg |
| Fibrinogen Related Peptide | 42-1-31B | 5 mg |
| Fibrinolysis Inhibiting Factor | 44-0-28A | 1 mg |
| Fibrinolysis Inhibiting Factor | 44-0-28B | 5 mg |
| Fibrinopeptide A, human | 42-1-12A | 1 mg |
| Fibrinopeptide A, human | 42-1-12B | 5 mg |
| Fibrinopeptide B, human | 42-1-21A | 1 mg |
| Fibrinopeptide B, human | 42-1-21B | 5 mg |
| Fibronectin Analog | 44-0-22 | 1 mg |
| Fibronectin CS1 Peptide | 44-0-42A | 1 mg |
| Fibronectin CS1 Peptide | 44-0-42B | 5 mg |
| Fibronectin Type III Connecting Segment (1-25) | 44-0-50A | 0.5 mg |
| Fibronectin Type III Connecting Segment (1-25) | 44-0-50B | 1 mg |
| Fibronectin-Binding Protein | 44-0-45A | 0.5 mg |
| Fibronectin-Binding Protein | 44-0-45B | 1 mg |
| G-dR-G-D-S-P | 44-0-47 | 1 mg |
| G-dR-G-D-S-P-A-S-S-K | 44-0-48 | 1 mg |
| G-Pen-G-R-G-D-S-P-C-A | 44-0-36 | 1 mg |
| G-P-R | 87-0-80 | 5 mg |
| G-R-A-D-S-P | 44-0-21A | 1 mg |
| G-R-G-D-dS-P | 44-0-38 | 1 mg |
| G-R-G-D-N-P | 44-0-65 | 1 mg |
| G-R-G-D-S | 44-0-23A | 1 mg |
| G-R-G-D-S | 44-0-23B | 5 mg |
| G-R-G-D-S-P | 44-0-24A | 1 mg |
| G-R-G-D-S-P-C | 44-0-25 | 1 mg |
| G-R-G-D-S-P-K | 44-0-39 | 1 mg |
| G-R-G-D-T-P | 44-0-46 | 1 mg |
| G-R-G-E-S | 44-0-51A | 1 mg |
| G-R-G-E-S | 44-0-51B | 5 mg |
| G-R-G-E-S-P | 44-0-26 | 1 mg |
| K-G-D-S | 44-0-31A | 1 mg |
| K-G-D-S | 44-0-31B | 5 mg |
| Necrofibrin, human | 42-1-10A | 1 mg |
| Necrofibrin, human | 42-1-10B | 5 mg |
| Necrofibrin, rat | 42-5-10A | 1 mg |
| Necrofibrin, rat | 42-5-10B | 5 mg |
| Platelet Membrane Glycoprotein IIB Peptide (296-306) | 44-0-40A | 0.5 mg |
| Platelet Membrane Glycoprotein IIB Peptide (296-306) | 44-0-40B | 1 mg |
| R-E-D-V | 44-0-12 | 5 mg |
| R-G-D | 44-0-19A | 1 mg |
| R-G-D | 44-0-19B | 5 mg |
| R-G-D-C | 44-0-13 | 5 mg |
| R-G-D-S | 44-0-14 | 5 mg |
| R-G-D-S-P-A-S-S-K-P | 44-0-15 | 1 mg |
| R-G-D-T | 44-0-16 | 5 mg |
| R-G-D-V | 44-0-17 | 5 mg |
| R-G-E-S | 44-0-18 | 5 mg |
| S-D-G-R | 44-0-32A | 1 mg |
| S-D-G-R | 44-0-32B | 5 mg |
| S-D-G-R-G | 44-0-33A | 1 mg |
| S-D-G-R-G | 44-0-33B | 5 mg |
| Y-R-G-D-S | 44-0-34A | 1 mg |
| Y-R-G-D-S | 44-0-34B | 5 mg |
Fluorescent Reagents | Biotin-C6-OH | QLB-REAG-101 | 1 mg |
| Biotin-C6-OSu | QLB-REAG-102 | 1 mg |
| Biotin-Dah | QLB-REAG-110 | 50 mg |
| Biotin-Dah-iodoacetyl | QLB-REAG-105 | 50 mg |
| Biotin-OSu | QLB-REAG-100 | 1 mg |
| Biotin-PEG2-Iodoacetyl | QLB-REAG-107 | 50 mg |
| Biotin-PEG2-Maleimide | QLB-REAG-109 | 50 mg |
| Biotin-PEG2-NH2 | QLB-REAG-112 | 50 mg |
| Fmoc-Lys(Biotin)-OH | QLB-REAG-115 | 1 mg |
| Fmoc-Lys(PEG3-Biotin)-OH | QLB-REAG-114 | 1 mg |
FMRF & Analogs | dF-M-R-F-NH2 | 60-0-35 | 5 mg |
| F-dM-R-F-NH2 | 60-0-33 | 5 mg |
| F-M-R-dF-NH2 | 60-0-34 | 5 mg |
| FMRF | 60-0-32 | 5 mg |
| FMRF Amide Related Peptide. | 60-9-30 | 1 mg |
| FMRF Amide-Like Peptide I, lobster | 60-9-28 | 1 mg |
| FMRF Amide-Like Peptide II, lobster | 60-9-29 | 1 mg |
| FMRF-amide | 60-9-17 | 5 mg |
| FMRF-Like Neuropeptide | 60-9-45 | 1 mg |
| FMRF-Like Peptide from snail Helix aspersa | 60-9-40 | 1 mg |
| L-P-L-R-F-NH2 | 60-0-42 | 5 mg |
| W-Nle-R-F-NH2 | 50-5-30A | 1 mg |
| W-Nle-R-F-NH2 | 50-5-30B | 5 mg |
| Y-F-M-R-F-NH2 | 60-0-30 | 5 mg |
| Y-L-P-L-R-F-NH2 | 60-0-43 | 5 mg |
| Y-M-R-F-NH2 | 60-0-31 | 5 mg |
FMRF & Analogs Galanins | Entero-Kassinin | 46-0-10 | 1 mg |
| Galanin (1-13)-Spantide I | 46-1-06A | 0.5 mg |
| Galanin (1-13)-Spantide I | 46-1-06B | 1 mg |
| Galanin (1-16), porcine, rat | 46-5-11A | 0.5 mg |
| Galanin (1-16), porcine, rat | 46-5-11B | 1 mg |
| Galanin (2-11) | 46-1-02A | 0.5 mg |
| Galanin (2-11) | 46-1-02B | 1 mg |
| Galanin, human | 46-1-01A | 0.5 mg |
| Galanin, human | 46-1-01B | 1 mg |
| Galanin, porcine | 46-1-10A | 0.5 mg |
| Galanin, porcine | 46-1-10B | 1 mg |
| Galanin, rat | 46-5-10 | 1 mg |
| Galantide | 46-1-08A | 0.5 mg |
| Galantide | 46-1-08B | 1 mg |
| GMAP (1-41), amide | 41-1-20A | 0.5 mg |
| GMAP (1-41), amide | 41-1-20B | 1 mg |
| GMAP (16-41), amide | 46-1-25A | 0.5 mg |
| GMAP (16-41), amide | 46-1-25B | 1 mg |
| GMAP (25-41), amide | 46-1-30A | 0.5 mg |
| GMAP (25-41), amide | 46-1-30B | 1 mg |
| M35 | 46-5-14A | 0.5 mg |
| M35 | 46-5-14B | 1 mg |
| M40 | 46-1-19A | 0.5 mg |
| M40 | 46-1-19B | 1 mg |
| Preprogalanin 28-67, rat | 46-1-03A | 0.5 mg |
| Preprogalanin 28-67, rat | 46-1-03B | 1 mg |
γ -Secretase Substrates | FITC labeled β -Amyloid (1-42) | 62-0-82A | 0.5 mg |
| Prion Protein Fragment (106-126), Human | 62-0-07A | 0.5 mg |
| Prion Protein Fragment (106-126), Human | 62-0-07B | 1 mg |
Gastric Inhibitory Peptides | (Pro3) Gastric Inhibitory Peptide (GIP), human | 46-1-34A | 0.5 mg |
| (Pro3) Gastric Inhibitory Peptide (GIP), human | 46-1-34B | 1 mg |
| [DAla2] Gastric Inhibitory Peptide (GIP), human | 46-1-67A | 0.5 mg |
| [DAla2] Gastric Inhibitory Peptide (GIP), human | 46-1-67B | 1 mg |
| [Tyr0] Gastric Inhibitory Peptide (23-42), human | 46-1-62A | 0.5 mg |
| [Tyr0] Gastric Inhibitory Peptide (23-42), human | 46-1-62B | 1 mg |
| Acetyl Gastric Inhibitory Peptide (human) | 46-1-43A | 0.5 mg |
| Acetyl Gastric Inhibitory Peptide (human) | 46-1-43B | 1 mg |
| Gastric Inhibitory Peptide (1-30), amide, porcine | 46-4-10A | 0.5 mg |
| Gastric Inhibitory Peptide (1-30), amide, porcine | 46-4-10B | 1 mg |
| Gastric Inhibitory Peptide (1-39), human | 46-1-66A | 0.5 mg |
| Gastric Inhibitory Peptide (1-39), human | 46-1-66B | 1 mg |
| Gastric Inhibitory Peptide (GIP), human | 46-1-60A | 0.5 mg |
| Gastric Inhibitory Peptide (GIP), human | 46-1-60B | 1 mg |
| Gastric Inhibitory Peptide, porcine | 46-4-30A | 0.5 mg |
| Gastric Inhibitory Peptide, porcine | 46-4-30B | 1 mg |
| Gastric Inhibitory Polypeptide (1-30), porcine | 46-1-27A | 0.5 mg |
| Gastric Inhibitory Polypeptide (1-30), porcine | 46-1-27B | 1 mg |
Ghrelins | (Des-octanoyl)-Ghrelin (human) | 55-0-05A | 0.5 mg |
| (Des-octanoyl)-Ghrelin (human) | 55-0-05B | 1 mg |
| [D-Lys3]-GHRP-6 | 52-1-83A | 0.5 mg |
| [D-Lys3]-GHRP-6 | 52-1-83B | 1 mg |
| Acetyl, Gastrin Releasing Peptide (20-27), porcine | 46-4-37 | 1 mg |
| Big Gastrin 1, human | 46-1-55A | 0.5 mg |
| Big Gastrin 1, human | 46-1-55B | 1 mg |
| Biotinyl-(Glu1)-Gastrin I (human) | 46-1-59A | 0.5 mg |
| Biotinyl-(Glu1)-Gastrin I (human) | 46-1-59B | 1 mg |
| Biotinyl-(Glu1)-Gastrin I (human) (phosphorylated) | 46-1-57A | 0.5 mg |
| Biotinyl-(Glu1)-Gastrin I (human) (phosphorylated) | 46-1-57B | 1 mg |
| Biotinyl-Obestatin, rat | 55-1-04A | 0.5 mg |
| Biotinyl-Obestatin, rat | 55-1-04B | 1 mg |
| Gastrin 1, human | 46-1-58 | 1 mg |
| Gastrin I, rat | 46-7-10A | 0.5 mg |
| Gastrin I, rat | 46-7-10B | 1 mg |
| Gastrin Releasing Peptide (1-16), human | 46-1-72 | 1 mg |
| Gastrin Releasing Peptide (1-16), porcine | 46-4-34 | 1 mg |
| Gastrin Releasing Peptide (14-27), porcine, human | 46-4-32 | 1 mg |
| Gastrin Releasing Peptide, human | 46-1-70A | 0.5 mg |
| Gastrin Releasing Peptide, human | 46-1-70B | 1 mg |
| Gastrin Releasing Peptide, porcine | 46-4-40A | 0.5 mg |
| Gastrin Releasing Peptide, porcine | 46-4-40B | 1 mg |
| Gastrin, chicken | 46-8-10A | 0.5 mg |
| Gastrin, chicken | 46-8-10B | 1 mg |
| Ghrelin, human | 55-0-02A | 0.5 mg |
| Ghrelin, human | 55-0-02B | 1 mg |
| Ghrelin, rat | 55-0-01A | 0.5 mg |
| Ghrelin, rat | 55-0-03A | 0.5 mg |
| Ghrelin, rat | 55-0-04A | 0.5 mg |
| Ghrelin, rat | 55-0-01B | 1 mg |
| Ghrelin, rat | 55-0-03B | 1 mg |
| Ghrelin, rat | 55-0-04B | 1 mg |
| Obestatin, Human | 55-1-01A | 0.5 mg |
| Obestatin, Human | 55-1-01B | 1 mg |
| Obestatin, rat, mouse | 55-1-02A | 0.5 mg |
| Obestatin, rat, mouse | 55-1-02B | 1 mg |
| Pentagastrin | 46-1-61A | 0.5 mg |
| Pentagastrin | 46-1-61B | 1 mg |
Glucagons and Glucagon-Like Peptides | (Ser8)-GLP-1 (7-36), amide, human | 46-1-05A | 0.5 mg |
| (Ser8)-GLP-1 (7-36), amide, human | 46-1-05B | 1 mg |
| [Des-His1,Glu9] Glucagon | 46-1-16A | 0.5 mg |
| [Des-His1,Glu9] Glucagon | 46-1-16B | 1 mg |
| [Des-His1,Glu9] Glucagon, amide | 46-1-17A | 0.5 mg |
| [Des-His1,Glu9] Glucagon, amide | 46-1-17B | 1 mg |
| Biotin-Glucagon-Like Peptide 1 (7-36), amide, human | 46-1-64A | 0.5 mg |
| Biotin-Glucagon-Like Peptide 1 (7-36), amide, human | 46-1-64B | 1 mg |
| Biotinyl-Glucagon (1-29), human, bovine, porcine | 46-1-26A | 0.5 mg |
| Biotinyl-Glucagon (1-29), human, bovine, porcine | 46-1-26B | 1 mg |
| GLP-1 (7-36), amide, chicken, common turkey | 46-0-90A | 0.5 mg |
| GLP-1 (7-36), amide, chicken, common turkey | 46-0-90B | 1 mg |
| GLP-1/Glucagon-Like Peptide, amide, human | 46-1-12A | 0.5 mg |
| GLP-1/Glucagon-Like Peptide, amide, human | 46-1-12B | 1 mg |
| GLP-1/Glucagon-Like Peptide, human | 46-1-11A | 0.5 mg |
| GLP-1/Glucagon-Like Peptide, human | 46-1-11B | 1 mg |
| GLP-2 (1-33), human | 46-0-80A | 0.5 mg |
| GLP-2 (1-33), human | 46-0-80B | 1 mg |
| Glucagon (19-29), human | 46-1-22A | 1 mg |
| Glucagon (19-29), human | 46-1-22B | 5 mg |
| Glucagon (22-29), human | 46-1-20 | 1 mg |
| Glucagon like peptide 1 (7-37) | 46-1-28A | 0.5 mg |
| Glucagon like peptide 1 (7-37) | 46-1-28B | 1 mg |
| Glucagon, human | 46-1-15A | 0.5 mg |
| Glucagon, human | 46-1-15B | 1 mg |
| Glucagon-Like Peptide 1 (7-36)-Lys(Biotin), amide, human | 46-1-65A | 0.5 mg |
| Glucagon-Like Peptide 1 (7-36)-Lys(Biotin), amide, human | 46-1-65B | 1 mg |
| Glucagon-Like Peptide I (7-36), amide, human | 46-1-13A | 0.5 mg |
| Glucagon-Like Peptide I (7-36), amide, human | 46-1-13B | 1 mg |
| Glucagon-Like Peptide II, (1-34), human | 46-1-14A | 0.5 mg |
| Glucagon-Like Peptide II, (1-34), human | 46-1-14B | 1 mg |
| Glucagon-Like Peptide II, rat | 46-4-18A | 0.5 mg |
| Glucagon-Like Peptide II, rat | 46-4-18B | 1 mg |
| Oxyntomodulin / Glucagon 37 | 46-1-18A | 0.5 mg |
| Oxyntomodulin / Glucagon 37 | 46-1-18B | 1 mg |
| Oxyntomodulin, human, mouse, rat | 46-1-46A | 0.5 mg |
| Oxyntomodulin, human, mouse, rat | 46-1-46B | 1 mg |
GnRH Associated Peptides | GnRH Associated Peptide (GAP) (1-13), human | 54-1-40 | 1 mg |
| GnRH Associated Peptide (GAP) (1-13), rat | 54-5-41 | 1 mg |
| GnRH Associated Peptide (GAP) (1-24), human | 54-1-39A | 0.5 mg |
| GnRH Associated Peptide (GAP) (1-24), human | 54-1-39B | 1 mg |
| GnRH Associated Peptide (GAP) (25-53), human | 54-1-38A | 0.5 mg |
| GnRH Associated Peptide (GAP) (25-53), human | 54-1-38B | 1 mg |
| Gonadotropin Releasing Peptide, follicular, human | 54-1-51 | 1 mg |
Growth Factor Fragments | [Cys(Acm)20,31] Epidermal Growth Factor (20-31) | 50-0-35 | 1 mg |
| a-TGF (34-43), rat | 50-5-22 | 1 mg |
| Brain Derived Acidic Fibroblast Growth Factor (102-111) | 50-0-32 | 1 mg |
| Brain Derived Acidic Fibroblast Growth Factor (1-11) | 50-0-27 | 1 mg |
| Brain Derived Basic Fibroblast Growth Factor (1-24) | 50-0-30A | 0.5 mg |
| Brain Derived Basic Fibroblast Growth Factor (1-24) | 50-0-30B | 1 mg |
| Epidermal Growth Factor Receptor Peptide (985-996) | 50-0-24 | 1 mg |
| Insulin-like 6 (INSL 6) / RIF-1 B-Chain, human | 50-1-40A | 0.5 mg |
| Insulin-like 6 (INSL 6) / RIF-1 B-Chain, human | 50-1-40B | 1 mg |
| Insulin-Like Growth [Tyr0] Factor II (33-40) | 50-1-32 | 1 mg |
| Insulin-Like Growth Factor I (24-41) | 50-1-29 | 1 mg |
| Insulin-Like Growth Factor I (30-41) | 50-1-24 | 1 mg |
| Insulin-Like Growth Factor I (57-70) | 50-1-22 | 1 mg |
| Insulin-Like Growth Factor II (33-40) | 50-1-31 | 1 mg |
| Insulin-Like Growth Factor II (69-84) | 50-1-37 | 1 mg |
| Liver Cell Growth Factor | 83-0-02 | 5 mg |
| Lys-Lys-IRS-1 (891-902) (dephosphorylated) human | 50-1-25A | 0.5 mg |
| Lys-Lys-IRS-1 (891-902) (dephosphorylated) human | 50-1-25B | 1 mg |
| N-Acetyl, a-TGF (34-43), Methyl Ester, rat | 50-5-25 | 1 mg |
| Preptin, human | 50-1-41 | 0.5 mg |
| Pro-TGF-a | 50-5-21A | 0.5 mg |
| Pro-TGF-a | 50-5-21B | 1 mg |
Growth Hormone & GHRFs | [Agm29] GHRH(1-29) antagonist peptide | 52-1-70 | 1 mg |
| [His1,Nle27] GHRF (1-32), amide, human | 52-1-59A | 0.5 mg |
| [His1,Nle27] GHRF (1-32), amide, human | 52-1-59B | 1 mg |
| Ac-[Agm29] GHRH(1-29) antagonist peptide | 52-1-71 | 1 mg |
| Ac-[DArg2] GHRF(1-29), amide, human | 52-1-69 | 1 mg |
| GHRF (1-29), amide, human | 52-1-60 | 1 mg |
| GHRF (1-29), amide, rat | 52-5-14 | 1 mg |
| GHRF (1-40), human | 52-1-53A | 0.5 mg |
| GHRF (1-40), human | 52-1-53B | 1 mg |
| GHRF (1-44), human | 52-1-50A | 0.5 mg |
| GHRF (1-44), human | 52-1-50B | 1 mg |
| GHRF, mouse | 52-1-10A | 0.5 mg |
| GHRF, mouse | 52-1-10B | 1 mg |
| GHRF, rat | 52-5-13A | 0.5 mg |
| GHRF, rat | 52-5-13B | 1 mg |
| GHRP-2 | 52-1-82A | 0.5 mg |
| GHRP-2 | 52-1-82B | 1 mg |
| GHRP-6 | 52-1-80A | 0.5 mg |
| GHRP-6 | 52-1-80B | 1 mg |
| Growth Hormone (1-43), human | 87-1-21 | 1 mg |
| Growth Hormone (6-13), human | 87-0-70 | 1 mg |
| Growth Hormone Pro-Releasing Factor, human | 52-1-67 | 1 mg |
GTP-Binding Protein Fragments | [Arg8] GTP-Binding Protein Fragment, Gs alpha | 77-0-02 | 1 mg |
| GTP-Binding Protein Fragment, G alpha | 77-0-00 | 1 mg |
| GTP-Binding Protein Fragment, G beta | 77-0-04 | 1 mg |
| GTP-Binding Protein Fragment, Go alpha | 77-0-03 | 1 mg |
| GTP-Binding Protein Fragment, Gs alpha | 77-0-01 | 1 mg |
Guanylins | Guanylin, human | 43-0-10A | 0.5 mg |
| Guanylin, human | 43-0-10B | 1 mg |
| Guanylin, rat, mouse | 43-0-12A | 0.5 mg |
| Guanylin, rat, mouse | 43-0-12B | 1 mg |
| Uroguanylin, human | 43-0-14A | 0.5 mg |
| Uroguanylin, human | 43-0-14B | 1 mg |
HBV | [Ala127] Hepatitis B Virus Pre-S Region (120-131) | 72-2-19A | 0.5 mg |
| [Ala127] Hepatitis B Virus Pre-S Region (120-131) | 72-2-19B | 1 mg |
| HBV Seq1 aa: 141-151 | 72-3-68A | 0.5 mg |
| HBV Seq1 aa: 141-151 | 72-3-68B | 1 mg |
| HBV Seq2 aa: 28-39 | 72-3-45A | 0.5 mg |
| HBV Seq2 aa: 28-39 | 72-3-45B | 1 mg |
| Hepatitis B Virus Pre-S Region (120-145) | 72-2-17A | 0.5 mg |
| Hepatitis B Virus Pre-S Region (120-145) | 72-2-17B | 1 mg |
HCV | Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala | 72-3-52A | 0.5 mg |
| Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala | 72-3-52B | 1 mg |
| HCV Core Protein (107-114) | 72-3-64A | 0.5 mg |
| HCV Core Protein (107-114) | 72-3-64B | 1 mg |
| HCV Core Protein (19-25) | 72-3-59A | 0.5 mg |
| HCV Core Protein (19-25) | 72-3-59B | 1 mg |
| HCV NS4A Protein (21-34) (JT strain) | 72-3-39A | 0.5 mg |
| HCV NS4A Protein (21-34) (JT strain) | 72-3-39B | 1 mg |
| HCV Peptide Aa: 257-266 | 72-3-63A | 0.5 mg |
| HCV Peptide Aa: 257-266 | 72-3-63B | 1 mg |
| HCV Peptide Aa: 35-44 | 72-3-66A | 0.5 mg |
| HCV Peptide Aa: 35-44 | 72-3-66B | 1 mg |
| HCV Peptide Aa:131-140 | 72-3-51A | 0.5 mg |
| HCV Peptide Aa:131-140 | 72-3-51B | 1 mg |
| HCV-1 e2 Protein (484-499) | 72-3-60A | 0.5 mg |
| HCV-1 e2 Protein (484-499) | 72-3-60B | 1 mg |
| HCV-1 e2 Protein (554-569) | 72-3-65A | 0.5 mg |
| HCV-1 e2 Protein (554-569) | 72-3-65B | 1 mg |
HIV | [Cys(Bzl)84] CD (81-92) | 72-1-30A | 1 mg |
| [Cys(Bzl)84] CD (81-92) | 72-1-30B | 5 mg |
| [DAla1] Peptide T, amide | 72-2-18A | 1 mg |
| [DAla1] Peptide T, amide | 72-2-18B | 5 mg |
| 2F5 epitope | 72-2-46A | 0.5 mg |
| 2F5 epitope | 72-2-46B | 1 mg |
| Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 81-7-20A | 1 mg |
| Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 81-7-20B | 5 mg |
| Alloferon 1 | 72-2-48A | 0.5 mg |
| Alloferon 1 | 72-2-48B | 1 mg |
| Alloferon 2 | 72-2-47A | 0.5 mg |
| Alloferon 2 | 72-2-47B | 1 mg |
| DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 72-3-30A | 0.5 mg |
| DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 72-3-30B | 1 mg |
| ELDKWA | 72-3-40A | 0.5 mg |
| ELDKWA | 72-3-40B | 1 mg |
| Herpes Virus Inhibitor 1 | 72-2-21A | 0.5 mg |
| Herpes Virus Inhibitor 1 | 72-2-21B | 1 mg |
| HIV (gp120) (318-327) | 72-3-34A | 0.5 mg |
| HIV (gp120) (318-327) | 72-3-34B | 1 mg |
| HIV Envelope Protein (254-274) | 72-3-38A | 0.5 mg |
| HIV Envelope Protein (254-274) | 72-3-38B | 1 mg |
| HIV Gag (129-135 ) | 72-2-50A | 1 mg |
| HIV Gag (129-135 ) | 72-2-50B | 5 mg |
| HIV Substrate | 72-2-45A | 1 mg |
| HIV Substrate | 72-2-45B | 5 mg |
| Peptide T | 72-2-16A | 1 mg |
| Peptide T | 72-2-16B | 5 mg |
| R15K, HIV-1 Inhibitory Peptide | 72-2-39A | 0.5 mg |
| R15K, HIV-1 Inhibitory Peptide | 72-2-39B | 1 mg |
Humanin | (Gly14)-Humanin, human | 81-3-16A | 0.5 mg |
| (Gly14)-Humanin, human | 81-3-16B | 1 mg |
| Humanin, human | 81-3-15A | 0.5 mg |
| Humanin, human | 81-3-15B | 1 mg |
Insect-Neuropeptides | Cockroach Myoactive Peptide I | 60-9-24 | 1 mg |
| Cockroach Myoactive Peptide II (MII) | 60-0-50 | 1 mg |
| Locustachykinin I | 87-7-60A | 0.5 mg |
| Locustachykinin I | 87-7-60B | 1 mg |
| Locustachykinin II | 87-7-65A | 0.5 mg |
| Locustachykinin II | 87-7-65B | 1 mg |
| SALMF amide 2 (S2) | 60-0-11 | 1 mg |
| SCPA | 60-0-60A | 1 mg |
| SCPA | 60-0-60B | 5 mg |
| SCPB | 60-0-58A | 1 mg |
| SCPB | 60-0-58B | 5 mg |
| Urechistachykinin I | 87-7-50A | 0.5 mg |
| Urechistachykinin I | 87-7-50B | 1 mg |
| Urechistachykinin II | 87-7-55A | 0.5 mg |
| Urechistachykinin II | 87-7-55B | 1 mg |
Isoleucine | Fmoc-Ile | FILE110A | 5 mg |
| Fmoc-Ile | FILE110B | 25 mg |
Laminin Peptides | Laminin (925-933) | 87-0-53A | 0.5 mg |
| Laminin (925-933) | 87-0-53B | 1 mg |
| Laminin (929-933) | 44-0-37 | 1 mg |
| Laminin A Chain (2091-2108) | 87-0-54A | 0.5 mg |
| Laminin A Chain (2091-2108) | 87-0-54B | 1 mg |
| Laminin Penta Peptide, amide | 87-0-55 | 1 mg |
Leptin Fragment Peptides | Leptin (116-130), amide, mouse | 46-2-18A | 0.5 mg |
| Leptin (116-130), amide, mouse | 46-2-18B | 1 mg |
| Leptin (116-130), mouse | 46-2-12A | 0.5 mg |
| Leptin (116-130), mouse | 46-2-12B | 1 mg |
| Leptin (22-56), human | 46-2-16A | 0.5 mg |
| Leptin (22-56), human | 46-2-16B | 1 mg |
| Leptin (93-105), human | 46-2-10A | 0.5 mg |
| Leptin (93-105), human | 46-2-10B | 1 mg |
| Tyr-Leptin (26-39), human | 46-2-14A | 0.5 mg |
| Tyr-Leptin (26-39), human | 46-2-14B | 1 mg |
Leucokinin & Analogs | Leucokinin I | 33-1-14 | 1 mg |
| Leucokinin II | 33-1-17 | 1 mg |
| Leucokinin III | 33-1-19 | 1 mg |
| Leucokinin IV | 33-1-21 | 1 mg |
| Leucokinin V | 33-1-23 | 1 mg |
| Leucokinin VII | 33-1-28 | 1 mg |
| Leucokinin VIII | 33-1-31 | 1 mg |
| Leucopyrokinin (LPK) | 33-1-11 | 1 mg |
LH-RH & Analogs | (Des-Gly10,DSer4,DLeu6,Pro-NHEt9)-LHRH | 54-1-14A | 1 mg |
| (Des-Gly10,DSer4,DLeu6,Pro-NHEt9)-LHRH | 54-1-14B | 5 mg |
| [(t-Bu)DSer6, (Aza)Gly10]-LH-RH | 54-1-20 | 5 mg |
| [DAla6,Des-Gly10] LH-RH, Ethyl Amide | 54-0-33 | 1 mg |
| [Des-Gly10, DLeu6, Pro9]-LH-RH, Ethyl Amide | 54-1-22 | 5 mg |
| [Des-Gly10] LH-RH, Ethyl Amide | 54-0-32 | 1 mg |
| [DLys6] LH-RH | 54-0-31 | 1 mg |
| [DSer(tBu)6, Des-Gly10]-LH-RH, Ethyl Amide | 54-1-23 | 5 mg |
| [DTrp6]-LH-RH Triptoreline, Ethyl Amide | 54-1-27 | 5 mg |
| [DTrp6]-LH-RH, amide | 54-1-21 | 5 mg |
| [Gln8] LH-RH, chicken | 54-8-23 | 1 mg |
| [Lys8] LH-RH | 54-0-28 | 1 mg |
| [Trp7,Leu8] LH-RH, Free Acid | 54-0-27 | 1 mg |
| Antide | 54-1-24A | 1 mg |
| Antide | 54-1-24B | 5 mg |
| GAP 26 | 54-1-41A | 0.5 mg |
| GAP 26 | 54-1-41B | 1 mg |
| GAP 27 | 54-1-42A | 0.5 mg |
| GAP 27 | 54-1-42B | 1 mg |
| LH-RH (4-10) | 54-1-13 | 1 mg |
| LH-RH II, chicken | 54-8-24 | 1 mg |
| LH-RH Sea Bream | 54-7-24 | 5 mg |
| LH-RH Sea Bream | 54-7-24A | 5 mg |
| LH-RH, Free Acid | 54-1-12 | 5 mg |
| LH-RH, human, Gonadoreline | 54-1-11 | 5 mg |
| LH-RH, lamprey | 54-7-26 | 1 mg |
| LH-RH, salmon | 54-7-25 | 1 mg |
| N-Acetyl [(pCl)DPhe1,2,DTrp3,DArg6,DAla10]-LH-RH | 54-0-38A | 0.5 mg |
| N-Acetyl [(pCl)DPhe1,2,DTrp3,DArg6,DAla10]-LH-RH | 54-0-38B | 1 mg |
Mast Cell Degranulating Peptides | Mast Cell Degranulating Peptide HR-1 | 41-9-10A | 1 mg |
| Mast Cell Degranulating Peptide HR-1 | 41-9-10B | 5 mg |
| Mast Cell Degranulating Peptide HR-2 | 41-9-20A | 1 mg |
| Mast Cell Degranulating Peptide HR-2 | 41-9-20B | 5 mg |
| MKKp2 | 41-9-11A | 1 mg |
| MKKp2 | 41-9-11B | 5 mg |
Melanin Concentrating Hormone (MCH) | Melanin Concentrating Hormone, rat | 72-0-62A | 0.5 mg |
| | 72-0-62B | 1 mg |
| | 72-0-61A | 0.5 mg |
| | 72-0-61B | 1 mg |
Melanocyte Stimulating Hormones (MSH) | [Ac-Cys4,DPhe7,Cys10] a-MSH (4-13), amide | 56-0-12 | 1 mg |
| [Des-Ac] a-MSH, amide | 56-0-24 | 1 mg |
| [Nle4,DPhe7] a-MSH, amide | 56-0-28 | 1 mg |
| Acetyl-(Lys0,Nle3)-g2-MSH amide | 56-0-31A | 0.5 mg |
| Acetyl-(Lys0,Nle3)-g2-MSH amide | 56-0-31B | 1 mg |
| Acetyl-(Nle4,Asp5,DTyr7,Lys10)-cyclo-a-MSH (4-10) amide | 56-0-30A | 0.5 mg |
| Acetyl-(Nle4,Asp5,DTyr7,Lys10)-cyclo-a-MSH (4-10) amide | 56-0-30B | 1 mg |
| a-MSH, amide | 56-1-11A | 1 mg |
| a-MSH, amide | 56-1-11B | 5 mg |
| a-MSH, Free Acid | 56-0-25 | 1 mg |
| b-MSH, human | 56-1-32 | 1 mg |
| b-MSH, porcine | 56-4-31 | 1 mg |
| DTrp-Gamma MSH | 56-0-13 | 1 mg |
| g-1-MSH, amide | 56-0-35 | 1 mg |
| g-MSH | 56-0-34 | 1 mg |
| MSH Release Inhibiting Factor, amide | 56-0-70 | 10 mg |
| N-Acetyl, [Nle4,DPhe7] a-MSH (4-10), amide | 56-0-29 | 1 mg |
Melanoma peptides | (Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | 55-0-13 | 1 mg |
| Antileukinate | 55-0-06A | 0.5 mg |
| Antileukinate | 55-0-06B | 1 mg |
| Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe | 55-0-10 | 1 mg |
| Ile-Met-Gln-Val-Pro-Phe-Ser-Val | 55-0-12 | 1 mg |
| Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | 55-0-11 | 1 mg |
| Kisspeptin-10 Metastin (45-54), Human | 55-0-15A | 0.5 mg |
| Kisspeptin-10 Metastin (45-54), Human | 55-0-15B | 1 mg |
| Kisspeptin-13 | 55-0-17A | 0.5 mg |
| Kisspeptin-13 | 55-0-17B | 1 mg |
| Mage-1 Antigen (161-169), human | 55-0-21 | 1 mg |
| MAGE-3 Antigen (167-176), human | 55-0-16 | 1 mg |
| MAGE-3 Antigen (271-279), human | 55-0-18 | 1 mg |
| MART-1(27-35), human | 55-0-22A | 1 mg |
| MART-1(27-35), human | 55-0-22B | 5 mg |
| Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp | 55-0-19 | 1 mg |
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | 55-0-20A | 0.5 mg |
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | 55-0-20B | 1 mg |
Miscellaneous Peptides | H-Cys-Val-2-Nal-Met-OH | 13-1-16B | 5 mg |
| (Arg)9 | 89-0-12A | 5 mg |
| (Arg)9 | 89-0-12B | 25 mg |
| (Ser140)-Myelin Proteolipid Protein (139-151) (depalmitoylated), human, bovine, dog, mouse, rat | 91-0-46A | 0.5 mg |
| (Ser140)-Myelin Proteolipid Protein (139-151) (depalmitoylated), human, bovine, dog, mouse, rat | 91-0-46B | 1 mg |
| [Ala 353, 367]Presenilin 1 (349-361) | 36-0-01 | 1 mg |
| 3X Flag Peptide | 82-8-21 | 1 mg |
| Ac-Asp-Glu | 60-0-55 | 5 mg |
| Acetyl-Myelin Basic Protein (Human, Rat, 1-11) | 91-0-51A | 1 mg |
| Acetyl-Myelin Basic Protein (Human, Rat, 1-11) | 91-0-51B | 5 mg |
| Ac-Phe-Gly-pNA | 81-0-16A | 5 mg |
| Ac-Phe-Gly-pNA | 81-0-16B | 25 mg |
| Ac-Pro-Gly-Pro (PGP ) | 89-0-11A | 5 mg |
| Ac-Pro-Gly-Pro (PGP ) | 89-0-11B | 25 mg |
| Ac-Ser-Asp-Lys-Pro | 87-0-25 | 5 mg |
| Adjuvant Peptide | 13-1-12 | 1 mg |
| Agr D1 thiolactone | 91-1-27A | 0.5 mg |
| Agr D1 thiolactone | 91-1-27B | 1 mg |
| Agr D2 thiolactone | 91-1-28A | 0.5 mg |
| Agr D2 thiolactone | 91-1-28B | 1 mg |
| a-Mating Factor (1-6) | 79-2-47 | 1 mg |
| a-Mating Factor, yeast | 83-0-60 | 1 mg |
| Anorexigenic Peptide | 87-0-10 | 1 mg |
| Antiarrhythmic Peptide (AAP) | 14-1-80 | 1 mg |
| Antiestrogen | 12-1-20A | 0.5 mg |
| Antiestrogen | 12-1-20B | 1 mg |
| Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder | 79-2-10A | 0.5 mg |
| Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder | 79-2-10B | 1 mg |
| Anxiety Peptide | 60-0-62 | 1 mg |
| BAFF-R (108-129) [Cys0], human | 81-1-16 | 1 mg |
| BAFF-R (151-175) [Cys0], mouse / BAFF-R (159-183) [Cys0], human | 81-1-17 | 1 mg |
| Beacon (30-73) | 46-2-79A | 10 ug |
| Beacon (30-73) | 46-2-79B | 0.5 mg |
| Beacon (47-73) | 46-2-80A | 0.5 mg |
| Beacon (47-73) | 46-2-80B | 1 mg |
| b-Interleukin I (163-171), human | 85-0-52 | 1 mg |
| b-Interleukin II (44-56) | 85-1-20 | 1 mg |
| Bovine Pineal Antireproductive Peptide | 87-0-57 | 1 mg |
| Bursin | 87-0-49 | 1 mg |
| c(RGDyK) | 13-1-23A | 1 mg |
| c(RGDyK) | 13-1-23B | 5 mg |
| C3 Peptide P16 | 79-4-10A | 0.5 mg |
| C3 Peptide P16 | 79-4-10B | 1 mg |
| Cadherin Peptide, avian | 79-1-20A | 0.5 mg |
| Cadherin Peptide, avian | 79-1-20B | 1 mg |
| Caloxin 2A1 | 22-7-20A | 0.5 mg |
| Caloxin 2A1 | 22-7-20B | 1 mg |
| C-G-Y-G-P-K-K-K-R-K-V-G-G | 79-2-11 | 1 mg |
| Chemotatic Peptide | 15-1-10 | 5 mg |
| Chromogranin A (324-337), human | 76-4-71 | 1 mg |
| Colivelin | 13-1-22A | 0.5 mg |
| Colivelin | 13-1-22B | 1 mg |
| Contraceptive Tetrapeptide | 87-0-51 | 5 mg |
| Crustacean Cardioactive Peptide (CCAP) | 14-1-84 | 1 mg |
| Crustacean Cardioactive Peptide (CCAP), amide | 14-1-95A | 0.5 mg |
| Crustacean Cardioactive Peptide (CCAP), amide | 14-1-95B | 1 mg |
| Crustacean Erythrophore Concentrating Hormone | 60-9-22 | 1 mg |
| C-telopeptide | 89-0-30A | 0.5 mg |
| C-telopeptide | 89-0-30B | 1 mg |
| D-D-D-D-D | 87-0-71 | 1 mg |
| D-D-D-D-D-D | 87-0-74 | 1 mg |
| Delicious Peptide | 87-0-69 | 1 mg |
| Delta (Phospho) Sleep Inducing Peptide | 87-0-59 | 1 mg |
| Delta Sleep Inducing Peptide | 87-0-56 | 1 mg |
| Des-[Gly77,His78] Myelin Basic Protein (68-84), bovine | 91-0-49 | 1 mg |
| dY-V-G | 60-0-61 | 1 mg |
| Egg Laying Hormone of Aplysia | 79-1-19A | 0.5 mg |
| Egg Laying Hormone of Aplysia | 79-1-19B | 1 mg |
| Ephrin-A2-Selective YSA-Peptide | 13-1-17A | 1 mg |
| Ephrin-A2-Selective YSA-Peptide | 13-1-17B | 5 mg |
| Experimental Allergic Encephalitogenic Peptide | 87-0-01A | 1 mg |
| Experimental Allergic Encephalitogenic Peptide | 87-0-01B | 5 mg |
| Farnesyltransferase inhibitor | 91-1-29A | 1 mg |
| Farnesyltransferase inhibitor | 91-1-29B | 5 mg |
| Fas C- Terminal Tripeptide | 81-1-15A | 1 mg |
| Flag Peptide | 82-8-20A | 0.5 mg |
| Flag Peptide | 82-8-20B | 1 mg |
| F-L-E-E-V | 87-0-58 | 5 mg |
| For-Met-Ala-Ser | 15-1-12 | 1 mg |
| Furin Convertase Inhibitor ( Chloromethylketone) | 13-1-11A | 0.5 mg |
| Furin Convertase Inhibitor ( Chloromethylketone) | 13-1-11B | 1 mg |
| G-A-Y | 79-3-15 | 5 mg |
| G-F-R | 87-0-73 | 20 mg |
| Gliadin (43-49)(Gliadorphin) Alpha | 24-1-12A | 5 mg |
| Gliadin (43-49)(Gliadorphin) Alpha | 24-1-12B | 25 mg |
| Glp-Trp-OEt | 13-1-20A | 250 mg |
| Glp-Trp-OEt | 13-1-20B | 1 g |
| Glp-Trp-OH | 13-1-21A | 250 mg |
| Glp-Trp-OH | 13-1-21B | 1 g |
| Helodermin | 73-0-12A | 0.5 mg |
| Helodermin | 73-0-12B | 1 mg |
| Helospectin II | 71-0-49 | 1 mg |
| Hexa-L-Tyrosine | 87-0-60A | 1 mg |
| Hexa-L-Tyrosine | 87-0-60B | 5 mg |
| Human IgE Pentapeptide HEPP | 82-0-51 | 5 mg |
| Ile-Arg-Ile-Cys(Me)-Arg-Lys-Gly-NH2 | 79-2-45A | 5 mg |
| Interleukin II (60-70) | 85-1-15 | 1 mg |
| K-F-H-E-K-H-H-S-H-R-G-Y | 79-2-41 | 1 mg |
| K-Q-A-G-D-V | 79-2-35 | 1 mg |
| Mas17 | 87-0-64 | 1 mg |
| Mas7 | 87-0-62 | 1 mg |
| MBP (146-170) | 91-0-54A | 0.5 mg |
| MBP (146-170) | 91-0-54B | 1 mg |
| MBP (83-99) | 91-0-53A | 0.5 mg |
| MBP (83-99) | 91-0-53B | 1 mg |
| Miraculin (1-20) | 82-8-10 | 1 mg |
| MOG (35-55) | 91-0-55A | 0.5 mg |
| MOG (35-55) | 91-0-55B | 1 mg |
| Myelin Basic Protein (68-82), guinea pig | 91-0-48 | 1 mg |
| Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 91-0-45A | 1 mg |
| Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 91-0-45 | 1 mg |
| Myelin Basic Protein (95-98) S5 Peptide MAP Kinase Substrate | 91-0-45B | 5 mg |
| Myelin Oligodendrocyte Glycoprotein Peptide (35-55), amide | 91-0-44A | 0.5 mg |
| Myelin Oligodendrocyte Glycoprotein Peptide (35-55), amide | 91-0-44B | 1 mg |
| Myelin Proteolipid Protein (139-151) (depalmitoylated) (human, bovine, dog, mouse, rat) | 91-0-50A | 0.5 mg |
| Myelin Proteolipid Protein (139-151) (depalmitoylated) (human, bovine, dog, mouse, rat) | 91-0-50B | 1 mg |
| Myomodulin | 91-1-10A | 1 mg |
| Myomodulin | 91-1-10B | 5 mg |
| Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell | 91-1-25A | 0.5 mg |
| Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell | 91-1-25B | 1 mg |
| Osteocalcin (1-43) | 22-1-67 | 10 ug |
| OVA 323-339 | 74-1-17A | 0.5 mg |
| OVA 323-339 | 74-1-17B | 1 mg |
| OVA Peptide | 74-1-18A | 0.5 mg |
| OVA Peptide | 74-1-18B | 1 mg |
| OVA peptide (257-264) | 74-1-16A | 0.5 mg |
| OVA peptide (257-264) | 74-1-16B | 1 mg |
| p-Aminophenylacetyl Tuftsin | 80-0-26 | 5 mg |
| Presenilin 1 (349-361) | 36-0-00 | 1 mg |
| Rac1 inhibitory | 13-1-10 | 10 ug |
| Rigin | 87-0-66 | 5 mg |
| R-S-R | 87-0-76A | 1 mg |
| R-S-R | 87-0-76B | 5 mg |
| Schizophrenia Related Peptide | 60-0-44 | 5 mg |
| Serum Thymic Factor | 87-0-04 | 1 mg |
| S-G-Q-S-W-R-P-Q-G-R-F, amide | 87-0-06 | 1 mg |
| SPAI-1, Sodium Potassium ATPase Inhibitor-1, porcine | 79-2-20A | 10 ug |
| Sperm Activating Peptide, Sea Urchin | 87-0-07 | 1 mg |
| Systemin | 79-3-10A | 0.5 mg |
| Systemin | 79-3-10B | 1 mg |
| Thrombin Receptor Agonist | 82-8-25A | 0.5 mg |
| Thrombin Receptor Agonist | 82-8-25B | 1 mg |
| TRAF6 (cell permeable) | 81-1-18 | 1 mg |
| TRAF6 Control | 81-1-19 | 1 mg |
| Tuftsin | 80-0-25 | 5 mg |
| Tumor Targeted Pro-Apoptotic Peptide | 13-1-18A | 1 mg |
| Tumor Targeted Pro-Apoptotic Peptide | 13-1-18B | 5 mg |
| Uremic Pentapeptide | 87-0-12A | 1 mg |
| Uremic Pentapeptide | 87-0-12B | 5 mg |
| V-A-I-T-V-L-V-K | 76-4-72A | 1 mg |
| V-A-I-T-V-L-V-K | 76-4-72B | 5 mg |
| Vanilloid Receptor Subtype 1 (VR1) | 87-0-52A | 1 mg |
| Vanilloid Receptor Subtype 1 (VR1) | 87-0-52B | 5 mg |
| V-G-V-R-V-R | 89-0-20 | 5 mg |
| V-I-H-S | 88-0-98 | 5 mg |
| V-P-D-P-R | 87-0-75 | 5 mg |
| V-T-C-G | 89-0-10 | 5 mg |
| WKYMVm | 15-1-11A | 1 mg |
| WKYMVm | 15-1-11B | 5 mg |
| WRW4 | 15-1-16 | 1 mg |
MMP Substrates | Elastase Substrate IV, Colorimetric | 76-4-74A | 0.5 mg |
| Elastase Substrate IV, Colorimetric | 76-4-74B | 1 mg |
| MMP Substrate III, Fluorogenic | 76-4-77A | 0.5 mg |
| MMP Substrate III, Fluorogenic | 76-4-77B | 1 mg |
| MMP Substrate V, Fluorogenic | 76-4-79A | 0.5 mg |
| MMP Substrate V, Fluorogenic | 76-4-79B | 1 mg |
| MMP Substrate, Fluorogenic | 81-7-70A | 0.5 mg |
| MMP Substrate, Fluorogenic | 81-7-70B | 1 mg |
| MMP-1 Substrate I, Flurogenic | 76-4-80A | 0.5 mg |
| MMP-1 Substrate I, Flurogenic | 76-4-80B | 1 mg |
| MMP-1 Substrate III, Fluorogenic | 76-4-81A | 0.5 mg |
| MMP-1 Substrate III, Fluorogenic | 76-4-81B | 1 mg |
| MMP-1/MMP-9 Substrate, Fluorogenic | 81-7-90 | 1 mg |
| MMP-13 Substrate, Fluorogenic | 76-4-82A | 0.5 mg |
| MMP-13 Substrate, Fluorogenic | 76-4-82B | 1 mg |
| MMP-2 Substrate, Fluorogenic | 76-4-85A | 0.5 mg |
| MMP-2 Substrate, Fluorogenic | 76-4-85B | 1 mg |
| MMP-2/MMP-7 Substrate | 76-4-73A | 0.5 mg |
| MMP-2/MMP-7 Substrate | 76-4-73B | 1 mg |
| MMP-2/MMP-7 Substrate Control, Fluorogenic | 76-4-86A | 0.5 mg |
| MMP-2/MMP-7 Substrate Control, Fluorogenic | 76-4-86B | 1 mg |
| MMP-2/MMP-9 Inhibitor III | 46-4-88A | 0.5 mg |
| MMP-2/MMP-9 Inhibitor III | 46-4-88B | 1 mg |
| MMP-2/MMP-9 Substrate I, Fluorogenic | 76-4-89A | 0.5 mg |
| MMP-2/MMP-9 Substrate I, Fluorogenic | 76-4-89B | 1 mg |
| MMP-7 Substrate (Matrilysin Substrate, PUMP-1 Substrate), Fluorogenic | 76-4-91A | 0.5 mg |
| MMP-7 Substrate (Matrilysin Substrate, PUMP-1 Substrate), Fluorogenic | 76-4-91B | 1 mg |
| MMP-8 Substrate, Fluorogenic (Neutrophil Collagenase Substrate) | 76-4-92A | 0.5 mg |
| MMP-8 Substrate, Fluorogenic (Neutrophil Collagenase Substrate) | 76-4-92B | 1 mg |
| Thrombin Substrate III, Fluorogenic | 76-4-96 | 1 mg |
Motilins | (Nle13, Glu14) Motilin, human, porcine | 48-4-23A | 0.5 mg |
| (Nle13, Glu14) Motilin, human, porcine | 48-4-23B | 1 mg |
| [Nle13]-Motillin | 48-4-24A | 0.5 mg |
| [Nle13]-Motillin | 48-4-24B | 1 mg |
| Motilin, canine | 48-6-10A | 0.5 mg |
| Motilin, canine | 48-6-10B | 1 mg |
| Motilin, human, porcine | 48-4-20A | 0.5 mg |
| Motilin, human, porcine | 48-4-20B | 1 mg |
Myelin Oligodendrocyte Glycoprotein (MOG) Peptide | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), rat, mouse | 91-0-47A | 0.5 mg |
| Myelin Oligodendrocyte Glycoprotein Peptide (35-55), rat, mouse | 91-0-47B | 1 mg |
Neuroendocrine Regulatory Peptides | NERP-1, human | 13-1-25A | 0.5 mg |
| NERP-1, human | 13-1-25B | 1 mg |
| NERP-1, rat | 13-1-26A | 0.5 mg |
| NERP-1, rat | 13-1-26B | 1 mg |
| NERP-2, human | 13-1-24A | 0.5 mg |
| NERP-2, human | 13-1-24B | 1 mg |
Neurokinins | (b-Ala8)-Neurokinin A (4-10) | 62-1-46A | 0.5 mg |
| (b-Ala8)-Neurokinin A (4-10) | 62-1-46B | 1 mg |
| (N-Me-Phe7)-Neurokinin B | 62-1-47A | 1 mg |
| (N-Me-Phe7)-Neurokinin B | 62-1-47B | 5 mg |
| [Ala5,b-Ala8] Neurokinin A (4-10) | 62-1-45A | 0.5 mg |
| [Ala5,b-Ala8] Neurokinin A (4-10) | 62-1-45B | 1 mg |
| [DPro2,DTrp6,8,Nle10] Neurokinin B | 62-0-45A | 0.5 mg |
| [DPro2,DTrp6,8,Nle10] Neurokinin B | 62-0-45B | 1 mg |
| [Lys5, MeLeu9, NIe10]-Neurokinin A (4-10) | 62-1-49A | 1 mg |
| [Lys5, MeLeu9, NIe10]-Neurokinin A (4-10) | 62-1-49B | 5 mg |
| [Ser2]-Neuromedin C | 62-3-10 | 0.5 mg |
| [Tyr5, DTrp6,8,9,Arg10] Neurokinin A (4-10) | 62-1-30A | 0.5 mg |
| [Tyr5, DTrp6,8,9,Arg10] Neurokinin A (4-10) | 62-1-30B | 1 mg |
| GR 83074 | 62-1-27A | 0.5 mg |
| GR 83074 | 62-1-27B | 1 mg |
| Hemokinin 1 (human) | 69-0-00A | 1 mg |
| Hemokinin 1 (human) | 69-0-00B | 5 mg |
| Neurokinin A (4-10) | 62-1-50 | 1 mg |
| Neurokinin A / Substance K | 62-1-40 | 1 mg |
| Neurokinin B | 62-1-42A | 0.5 mg |
| Neurokinin B | 62-1-42B | 1 mg |
| PG-KII | 62-0-43A | 0.5 mg |
| PG-KII | 62-0-43B | 1 mg |
Neuromedins | Neuromedin (B-30) | 62-0-52A | 0.5 mg |
| Neuromedin (B-30) | 62-0-52B | 1 mg |
| Neuromedin (U25), human | 62-0-54A | 0.5 mg |
| Neuromedin (U25), human | 62-0-54B | 1 mg |
| Neuromedin (U25), porcine | 62-0-53A | 0.5 mg |
| Neuromedin (U25), porcine | 62-0-53B | 1 mg |
| Neuromedin (U8), porcine | 62-0-50 | 1 mg |
| Neuromedin B | 62-0-47 | 1 mg |
| Neuromedin C | 62-0-49 | 1 mg |
| Neuromedin N | 62-4-31 | 1 mg |
| Neuromedin S, rat | 62-5-52A | 0.5 mg |
| Neuromedin S, rat | 62-5-52B | 1 mg |
| Neuromedin U, rat | 62-5-50A | 0.5 mg |
| Neuromedin U, rat | 62-5-50B | 1 mg |
Neuropeptide Y & Analogs | [D-Arg25]-Neuropeptide Y, human, rat | 60-1-27A | 0.5 mg |
| [D-Arg25]-Neuropeptide Y, human, rat | 60-1-27B | 1 mg |
| [DTrp32]Neuropeptide Y (1-36), human | 60-1-21A | 0.5 mg |
| [DTrp32]Neuropeptide Y (1-36), human | 60-1-21B | 1 mg |
| [D-Trp34]-Neuropeptide Y, human | 60-1-31A | 0.5 mg |
| [D-Trp34]-Neuropeptide Y, human | 60-1-31B | 1 mg |
| [Leu17,DTrp32] Neuropeptide Y, human | 60-1-14A | 0.5 mg |
| [Leu17,DTrp32] Neuropeptide Y, human | 60-1-14B | 1 mg |
| [Leu31,Pro34] Neuropeptide Y (1-36), porcine | 60-4-14A | 0.5 mg |
| [Leu31,Pro34] Neuropeptide Y (1-36), porcine | 60-4-14B | 1 mg |
| [Leu31,Pro34] Neuropeptide Y, human | 60-1-20A | 0.5 mg |
| [Leu31,Pro34] Neuropeptide Y, human | 60-1-20B | 1 mg |
| [Pro34] Neuropeptide Y (1-36), human | 60-1-18A | 0.5 mg |
| [Pro34] Neuropeptide Y (1-36), human | 60-1-18B | 1 mg |
| [Pro34] Neuropeptide Y, porcine | 60-4-13A | 0.5 mg |
| [Pro34] Neuropeptide Y, porcine | 60-4-13B | 1 mg |
| [Thr30]-Neuropeptide Y, human | 60-1-30A | 0.5 mg |
| [Thr30]-Neuropeptide Y, human | 60-1-30B | 1 mg |
| [Try(OMe)21] Neuropeptide Y, human | 60-1-15A | 0.5 mg |
| [Try(OMe)21] Neuropeptide Y, human | 60-1-15B | 1 mg |
| Ac-[Leu28,31] Neuropeptide Y (24-36), human | 60-1-19A | 0.5 mg |
| Ac-[Leu28,31] Neuropeptide Y (24-36), human | 60-1-19B | 1 mg |
| BIBP 3226 | 60-1-22A | 0.5 mg |
| BIBP 3226 | 60-1-22B | 1 mg |
| Biotin-Neuropeptide Y | 60-4-19A | 0.5 mg |
| Biotin-Neuropeptide Y | 60-4-19B | 1 mg |
| Neuropeptide Y (1-24), human | 60-1-10A | 0.5 mg |
| Neuropeptide Y (1-24), human | 60-1-10B | 1 mg |
| Neuropeptide Y (13-36) (porcine) | 60-4-11A | 0.5 mg |
| Neuropeptide Y (13-36) (porcine) | 60-4-11B | 1 mg |
| Neuropeptide Y (13-36), human | 60-1-16A | 0.5 mg |
| Neuropeptide Y (13-36), human | 60-1-16B | 1 mg |
| Neuropeptide Y (2-36) (human, rat) | 60-1-33A | 0.5 mg |
| Neuropeptide Y (2-36) (human, rat) | 60-1-33B | 1 mg |
| Neuropeptide Y (2-36), amide, porcine | 60-4-20A | 0.5 mg |
| Neuropeptide Y (2-36), amide, porcine | 60-4-20B | 1 mg |
| Neuropeptide Y (3-36), human | 60-1-17A | 0.5 mg |
| Neuropeptide Y (3-36), human | 60-1-17B | 1 mg |
| Neuropeptide Y, human | 60-1-11A | 0.5 mg |
| Neuropeptide Y, human | 60-1-11B | 1 mg |
| Neuropeptide Y, porcine | 60-4-15A | 0.5 mg |
| Neuropeptide Y, porcine | 60-4-15B | 1 mg |
| Neuropeptide Y, porcine, Free Acid | 60-4-18A | 0.5 mg |
| Neuropeptide Y, porcine, Free Acid | 60-4-18B | 1 mg |
| Neuropeptide Y, sheep | 60-1-35A | 0.5 mg |
| Neuropeptide Y, sheep | 60-1-35B | 1 mg |
| Neuropeptide Y-Lys(Biotin), human, rat | 60-1-32A | 0.5 mg |
| Neuropeptide Y-Lys(Biotin), human, rat | 60-1-32B | 1 mg |
| Pancreatic Polypeptide Fragment 1-17-[Ala31, alpha-Aminoisobutryl32]-Neuropeptide Y Fragment 18-36 | 60-1-26A | 0.5 mg |
| Pancreatic Polypeptide Fragment 1-17-[Ala31, alpha-Aminoisobutryl32]-Neuropeptide Y Fragment 18-36 | 60-1-26B | 1 mg |
Neuropeptides & Related Peptides | (Des-Bromo)-Neuropeptide B (1-23) (human) | 60-2-00A | 0.5 mg |
| (Des-Bromo)-Neuropeptide B (1-23) (human) | 60-2-00B | 1 mg |
| [Des-Ser1] Cerebellin | 88-0-46A | 0.5 mg |
| [Des-Ser1] Cerebellin | 88-0-46B | 1 mg |
| [His7] Corazonin | 60-9-54A | 1 mg |
| [His7] Corazonin | 60-9-54B | 5 mg |
| A-18-F-NH2; Morphine Modulating Neuropeptide | 32-3-13A | 0.5 mg |
| A-18-F-NH2; Morphine Modulating Neuropeptide | 32-3-13B | 1 mg |
| Alytesin | 62-0-66A | 1 mg |
| Alytesin | 62-0-66B | 5 mg |
| Buccalin | 87-0-20A | 1 mg |
| Buccalin | 87-0-20B | 5 mg |
| Cerebellin | 60-1-53 | 1 mg |
| Corazonin | 60-9-50A | 1 mg |
| Corazonin | 60-9-50B | 5 mg |
| Cortistatin-17, human | 34-7-35A | 0.5 mg |
| Cortistatin-17, human | 34-7-35B | 1 mg |
| Diazepam-Binding Inhibitor Fragment, human | 60-1-70 | 1 mg |
| Eledoisin | 62-0-56 | 1 mg |
| Eledoisin Related Peptide | 62-0-58 | 1 mg |
| g-Neuropeptide, rabbit | 60-7-20A | 0.5 mg |
| g-Neuropeptide, rabbit | 60-7-20B | 1 mg |
| Granuliberin R | 87-0-72 | 1 mg |
| Head Activator Neuropeptide | 60-0-48 | 1 mg |
| Kassinin | 62-0-55 | 1 mg |
| Kinetensin | 62-0-32 | 1 mg |
| Levitide | 62-7-15 | 1 mg |
| Litorin | 62-0-62 | 1 mg |
| Mastoparan | 87-0-61 | 1 mg |
| Mastoparan X | 87-0-67 | 1 mg |
| Melanostatin, frog | 60-0-20A | 0.5 mg |
| Melanostatin, frog | 60-0-20B | 1 mg |
| Men 10376 | 62-1-39A | 0.5 mg |
| Men 10376 | 62-1-39B | 1 mg |
| Neuron Specific Peptide | 60-0-75A | 0.5 mg |
| Neuron Specific Peptide | 60-0-75B | 1 mg |
| Neuropeptide EI-Gly-Arg-Arg-MCH, human, mouse, rat | 60-1-37A | 0.5 mg |
| Neuropeptide EI-Gly-Arg-Arg-MCH, human, mouse, rat | 60-1-37B | 1 mg |
| Neuropeptide FF Morphine Modulating Neuropeptide | 32-0-64 | 1 mg |
| Neuropeptide K, porcine | 60-4-16A | 0.5 mg |
| Neuropeptide K, porcine | 60-4-16B | 1 mg |
| Neuropeptide S, rat | 60-1-36A | 0.5 mg |
| Neuropeptide S, rat | 60-1-36B | 1 mg |
| Neuropeptide W-23 (human) | 61-0-00A | 0.5 mg |
| Neuropeptide W-23 (human) | 61-0-00B | 1 mg |
| Neuropeptide W-23 (rat) | 61-0-01A | 0.5 mg |
| Neuropeptide W-23 (rat) | 61-0-01B | 1 mg |
| Nocistatin (25-30), human | 32-0-09A | 0.5 mg |
| Nocistatin (25-30), human | 32-0-09B | 1 mg |
| Phyllomedusin | 62-0-68 | 1 mg |
| Physalaemin | 62-0-57 | 1 mg |
| Polistes Mastoparan | 87-0-68 | 1 mg |
| Proctolin | 60-0-52 | 1 mg |
| Ranatensin | 62-0-60 | 1 mg |
| Spexin/NPQ human, mouse, bovine | 13-1-27A | 0.5 mg |
| Spexin/NPQ human, mouse, bovine | 13-1-27B | 1 mg |
| Tyr-W-MIF-1 | 60-0-21A | 0.5 mg |
| Tyr-W-MIF-1 | 60-0-21B | 1 mg |
| Uperolein | 62-0-67 | 1 mg |
| Xenopsin | 62-0-64 | 1 mg |
| Xenopsin-related Peptide I | 62-0-63 | 1 mg |
| Xenopsin-related Peptide II | 63-0-65 | 1 mg |
Neurotensins | (Dab9)-Neurotensin (8-13) | 62-1-62A | 5 mg |
| (Dab9)-Neurotensin (8-13) | 62-1-62B | 25 mg |
| (Lys8,Lys9)-Neurotensin (8-13) | 62-0-29 | 1 mg |
| (Lys8-acetyl-Lys9)-Neurotensin (8-13) | 62-1-65A | 5 mg |
| (Lys8-acetyl-Lys9)-Neurotensin (8-13) | 62-1-65B | 25 mg |
| (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | 62-1-63A | 1 mg |
| (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | 62-1-63B | 5 mg |
| [DTrp11] Neurotensin | 62-1-23 | 1 mg |
| [DTyr11] Neurotensin | 62-1-10 | 1 mg |
| [Lys8,Asn9] Neurotensin LANT-6 (8-13) | 62-0-28 | 1 mg |
| [Trp11] Neurotensin (8-13) | 62-1-12 | 1 mg |
| [Trp11]-Neurotensin | 62-1-60A | 5 mg |
| [Trp11]-Neurotensin | 62-1-60B | 25 mg |
| Boc-(Lys9)-Neurotensin (9-13)-methyl ester | 62-1-64A | 50 mg |
| Boc-(Lys9)-Neurotensin (9-13)-methyl ester | 62-1-64B | 250 mg |
| Neurotensin | 60-1-12 | 1 mg |
| Neurotensin (1-6) | 62-1-21 | 1 mg |
| Neurotensin (1-8) | 62-1-61A | 5 mg |
| Neurotensin (1-8) | 62-1-61B | 25 mg |
| Neurotensin (8-13) | 62-1-24 | 1 mg |
| Neurotensin (8-13), N-Acetyl | 62-1-26 | 1 mg |
| Neurotensin (9-13) | 62-1-16A | 5 mg |
| Neurotensin (9-13) | 62-1-16B | 25 mg |
Opioid Related Peptides | [DAla2] Deltorphin I | 28-9-10A | 1 mg |
| [DAla2] Deltorphin I | 28-9-10B | 5 mg |
| [DAla2] Deltorphin II | 28-9-20A | 1 mg |
| [DAla2] Deltorphin II | 28-9-20B | 5 mg |
| [DArg2] Dermorphin (1-4), amide | 32-0-44A | 1 mg |
| [DArg2] Dermorphin (1-4), amide | 32-0-44B | 5 mg |
| Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | 32-0-54 | 1 mg |
| a-Casein (90-95) | 32-3-25 | 1 mg |
| Adrenal Peptide E, bovine | 30-3-35 | 1 mg |
| Adrenorphin | 30-0-50A | 1 mg |
| Adrenorphin | 30-0-50B | 5 mg |
| BAM (8-22) | 30-3-29A | 0.5 mg |
| BAM (8-22) | 30-3-29B | 1 mg |
| BAM-12P | 30-3-20 | 1 mg |
| BAM-18P | 30-3-25 | 1 mg |
| BAM-22P | 30-3-30 | 1 mg |
| Biphalin | 30-0-61A | 0.5 mg |
| Biphalin | 30-0-61B | 1 mg |
| Crystalline | 32-0-12 | 1 mg |
| DAGO | 32-0-75 | 1 mg |
| Dermorphin | 32-0-40A | 1 mg |
| Dermorphin | 32-0-40B | 5 mg |
| Kyotorphin | 32-0-50 | 5 mg |
| Morphin, Tolerance Peptide | 32-0-60 | 5 mg |
| Morphine Modulating Peptide, C-Terminal Fragment | 32-0-67 | 1 mg |
| Nociceptin (1-13)-NH2/ Orphanin FQ | 32-0-14A | 0.5 mg |
| Nociceptin (1-13)-NH2/ Orphanin FQ | 32-0-14B | 1 mg |
| Nociceptin / Orphanin FQ | 32-0-10A | 0.5 mg |
| Nociceptin / Orphanin FQ | 32-0-10B | 1 mg |
| OFQ | 30-1-10A | 0.5 mg |
| OFQ | 30-1-10B | 1 mg |
| Orphan GPCR SP9155 Agonist P518 | 13-1-15 | 0.5 mg |
| Peptide B, bovine | 30-3-10A | 0.5 mg |
| Peptide B, bovine | 30-3-10B | 1 mg |
| Peptide F, bovine | 30-3-40 | 1 mg |
Orexins | (Ala11,D-Leu15)-Orexin B, human | 46-2-78A | 0.5 mg |
| (Ala11,D-Leu15)-Orexin B, human | 46-2-78B | 1 mg |
| Orexin A, human | 46-2-70A | 0.5 mg |
| Orexin A, human | 46-2-70B | 1 mg |
| Orexin B, canine | 46-2-73A | 0.5 mg |
| Orexin B, canine | 46-2-73B | 1 mg |
| Orexin B, human | 46-2-71A | 0.5 mg |
| Orexin B, human | 46-2-71B | 1 mg |
| Orexin B, rat, mouse | 46-2-72A | 0.5 mg |
| Orexin B, rat, mouse | 46-2-72B | 1 mg |
Oxytocins | [Asu 1,6] Oxytocin | 66-0-51 | 1 mg |
| [Ile3] Pressinoic Acid | 66-0-53 | 1 mg |
| [Thr4,Gly7] Oxytocin | 66-0-59A | 1 mg |
| [Thr4,Gly7] Oxytocin | 66-0-59B | 5 mg |
| Oxytocin | 66-0-52 | 5 mg |
| Pressinoic Acid | 66-0-69 | 1 mg |
Pancreastatin & Related Peptides | [Tyr0,Nle8] Pancreastatin, porcine | 46-4-45A | 0.5 mg |
| [Tyr0,Nle8] Pancreastatin, porcine | 46-4-45B | 1 mg |
| Chromostatin, bovine | 46-4-70A | 0.5 mg |
| Chromostatin, bovine | 46-4-70B | 1 mg |
| Pancreastatin (33-49), porcine | 46-4-42A | 0.5 mg |
| Pancreastatin (33-49), porcine | 46-4-42B | 1 mg |
| Pancreastatin (37-52), human | 46-4-62 | 1 mg |
| Pancreastatin [Tyr0], porcine | 46-4-44B | 1 mg |
| Pancreastatin [Tyr0], porcine | 46-4-44A | 0.5 mg |
| Pancreastatin, porcine | 46-4-60A | 0.5 mg |
| Pancreastatin, porcine | 46-4-60B | 1 mg |
| Xenin | 46-4-73A | 0.5 mg |
| Xenin | 46-4-73B | 1 mg |
Pancreatic Polypeptides | Pancreatic Polypeptide (31-36) Free Acid, human | 46-1-73 | 1 mg |
| Pancreatic Polypeptide (31-36), amide, human | 46-1-71 | 1 mg |
| Pancreatic Polypeptide, avian | 46-8-25A | 0.5 mg |
| Pancreatic Polypeptide, avian | 46-8-25B | 1 mg |
| Pancreatic Polypeptide, human | 46-1-69A | 0.5 mg |
| Pancreatic Polypeptide, human | 46-1-69B | 1 mg |
| Pancreatic Polypeptide, rat | 46-5-20A | 0.5 mg |
| Pancreatic Polypeptide, rat | 46-5-20B | 1 mg |
Parathyroid Hormone & Analogs (PTH) | [Asn76] Parathyroid Hormone (64-84), human | 22-1-41 | 1 mg |
| [Asn8, Leu18] Parathyroid Hormone (1-34), human | 22-3-30A | 0.5 mg |
| [Asn8, Leu18] Parathyroid Hormone (1-34), human | 22-3-30B | 1 mg |
| [Nle8,18, Tyr34] Parathyroid Hormone (1-34), human | 22-1-27A | 0.5 mg |
| [Nle8,18, Tyr34] Parathyroid Hormone (1-34), human | 22-1-27B | 1 mg |
| [Nle8,18,Tyr34] Parathyroid Hormone (3-34), amide, human | 22-1-33A | 0.5 mg |
| [Nle8,18,Tyr34] Parathyroid Hormone (3-34), amide, human | 22-1-33B | 1 mg |
| [Nle8,18,Tyr34] Parathyroid Hormone (7-34), amide, bovine | 22-3-21 | 1 mg |
| [Nle8,21,Tyr34] Parathyroid Hormone (1-34), amide, rat | 22-5-25A | 0.5 mg |
| [Nle8,21,Tyr34] Parathyroid Hormone (1-34), amide, rat | 22-5-25B | 1 mg |
| [Tyr1] Parathyroid Hormone (1-34), human | 22-1-24A | 0.5 mg |
| [Tyr1] Parathyroid Hormone (1-34), human | 22-1-24B | 1 mg |
| [Tyr27] Parathyroid Hormone (27-48), human | 22-1-26A | 0.5 mg |
| [Tyr27] Parathyroid Hormone (27-48), human | 22-1-26B | 1 mg |
| [Tyr34] Parathyroid Hormone (7-34), amide, bovine | 22-3-25A | 0.5 mg |
| [Tyr34] Parathyroid Hormone (7-34), amide, bovine | 22-3-25B | 1 mg |
| [Tyr43] Parathyroid Hormone (43-68), human | 22-1-43A | 0.5 mg |
| [Tyr43] Parathyroid Hormone (43-68), human | 22-1-43B | 1 mg |
| [Tyr63] Parathyroid Hormone (63-84), human | 22-1-49 | 1 mg |
| Biotin-Parathyroid Hormone (1-34), human | 22-1-44A | 0.5 mg |
| Biotin-Parathyroid Hormone (1-34), human | 22-1-44B | 1 mg |
| Biotinyl-PTH-Related Protein (1-34), human, rat | 22-1-75A | 0.5 mg |
| Biotinyl-PTH-Related Protein (1-34), human, rat | 22-1-75B | 1 mg |
| Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 22-1-20A | 0.5 mg |
| Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 22-1-20B | 1 mg |
| Hypercalcemia Malignancy Factor (1-34), amide, human | 22-1-71A | 0.5 mg |
| Hypercalcemia Malignancy Factor (1-34), amide, human | 22-1-71B | 1 mg |
| Hypercalcemia Malignancy Factor (1-34), human | 22-1-74A | 0.5 mg |
| Hypercalcemia Malignancy Factor (1-34), human | 22-1-74B | 1 mg |
| Hypercalcemia Malignancy Factor (7-34), amide, human | 22-1-73A | 0.5 mg |
| Hypercalcemia Malignancy Factor (7-34), amide, human | 22-1-73B | 1 mg |
| Parathyroid Hormone (13-34), human | 22-1-32A | 0.5 mg |
| Parathyroid Hormone (13-34), human | 22-1-32B | 1 mg |
| Parathyroid Hormone (1-34), bovine | 22-3-15A | 0.5 mg |
| Parathyroid Hormone (1-34), bovine | 22-3-15B | 1 mg |
| Parathyroid Hormone (1-34), human | 22-1-25A | 0.5 mg |
| Parathyroid Hormone (1-34), human | 22-1-25B | 1 mg |
| Parathyroid Hormone (1-34), rat | 22-5-21A | 0.5 mg |
| Parathyroid Hormone (1-34), rat | 22-5-21B | 1 mg |
| Parathyroid Hormone (1-34)-Lys(Biotin), human | 22-1-21A | 0.5 mg |
| Parathyroid Hormone (1-34)-Lys(Biotin), human | 22-1-21B | 1 mg |
| Parathyroid Hormone (1-38), human | 22-1-30A | 0.5 mg |
| Parathyroid Hormone (1-38), human | 22-1-30B | 1 mg |
| Parathyroid Hormone (1-44), human | 22-1-22A | 0.5 mg |
| Parathyroid Hormone (1-44), human | 22-1-22B | 1 mg |
| Parathyroid Hormone (28-48), human | 22-1-29A | 0.5 mg |
| Parathyroid Hormone (28-48), human | 22-1-29B | 1 mg |
| Parathyroid Hormone (3-34), bovine | 22-3-22A | 0.5 mg |
| Parathyroid Hormone (3-34), bovine | 22-3-22B | 1 mg |
| Parathyroid Hormone (39-68), human | 22-1-35A | 0.5 mg |
| Parathyroid Hormone (39-68), human | 22-1-35B | 1 mg |
| Parathyroid Hormone (39-84), human | 22-1-40A | 0.5 mg |
| Parathyroid Hormone (39-84), human | 22-1-40B | 1 mg |
| Parathyroid Hormone (44-68), human | 22-1-42A | 0.5 mg |
| Parathyroid Hormone (44-68), human | 22-1-42B | 1 mg |
| Parathyroid Hormone (53-84), human | 22-1-45A | 0.5 mg |
| Parathyroid Hormone (53-84), human | 22-1-45B | 1 mg |
| Parathyroid Hormone (69-84), human | 22-1-46A | 0.5 mg |
| Parathyroid Hormone (69-84), human | 22-1-46B | 1 mg |
| Parathyroid Hormone (70-84), human | 22-1-57 | 1 mg |
| Parathyroid Hormone Related Peptide (107-111) | 22-1-60 | 5 mg |
| TIP-39 | 22-1-31A | 0.5 mg |
| TIP-39 | 22-1-31B | 1 mg |
Peptides YY | [Leu31, Pro34]Peptide YY, PYY, human | 48-0-31A | 0.5 mg |
| [Leu31, Pro34]Peptide YY, PYY, human | 48-0-31B | 1 mg |
| [Pro34]Peptide YY, PYY, human | 48-0-32A | 0.5 mg |
| [Pro34]Peptide YY, PYY, human | 48-0-32B | 1 mg |
| Peptide YY(3-36), PYY, human | 48-0-33A | 0.5 mg |
| Peptide YY(3-36), PYY, human | 48-0-33B | 1 mg |
| Peptide YY, PYY, human | 48-0-30A | 0.5 mg |
| Peptide YY, PYY, human | 48-0-30B | 1 mg |
| Peptide YY, PYY, porcine | 48-0-40A | 0.5 mg |
| Peptide YY, PYY, porcine | 48-0-40B | 1 mg |
Petidase Substrates | Rhodamine 110, bis-(CBZ-L-isoleucyl-L-prolyl-L- arginine amide), dihydrochloride (BZiPAR) | 82-0-04A | 0.5 mg |
| Rhodamine 110, bis-(CBZ-L-isoleucyl-L-prolyl-L- arginine amide), dihydrochloride (BZiPAR) | 82-0-04B | 1 mg |
| Rhodamine 110, bis-(succinoyl-L-alanyl-L-alanyl-L- prolyl-L-phenylalanyl amide) | 82-0-07A | 0.5 mg |
| Rhodamine 110, bis-(succinoyl-L-alanyl-L-alanyl-L- prolyl-L-phenylalanyl amide) | 82-0-07B | 1 mg |
Phalloidins | [Asp7]Phalloidin | 92-5-10A | 1 mg |
| [Asp7]Phalloidin | 92-5-10B | 5 mg |
| [Dap7]Phalloidin | 92-2-10A | 1 mg |
| [Dap7]Phalloidin | 92-2-10B | 5 mg |
| [Lys7]Phalloidin | 92-3-10A | 1 mg |
| [Lys7]Phalloidin | 92-3-10B | 5 mg |
| [Orn7]Phalloidin | 92-4-10A | 1 mg |
| [Orn7]Phalloidin | 92-4-10B | 5 mg |
| 5-FAM-[Dap7]Phalloidin | 92-2-12A | 1 mg |
| 5-FAM-[Dap7]Phalloidin | 92-2-12B | 5 mg |
| 5-FAM-[Lys7]Phalloidin | 92-3-14A | 1 mg |
| 5-FAM-[Lys7]Phalloidin | 92-3-14B | 5 mg |
| 5-FAM-Phalloidin | 92-0-12A | 1 mg |
| 5-FAM-Phalloidin | 92-0-12B | 5 mg |
| 5-TAMRA-[Dap7]Phalloidin | 92-2-14A | 1 mg |
| 5-TAMRA-[Dap7]Phalloidin | 92-2-14B | 5 mg |
| 5-TAMRA-[Lys7]Phalloidin | 92-3-15A | 1 mg |
| 5-TAMRA-[Lys7]Phalloidin | 92-3-15B | 5 mg |
| 5-TAMRA-Phalloidin | 92-0-13A | 1 mg |
| 5-TAMRA-Phalloidin | 92-0-13B | 5 mg |
| Amino-Phalloidin, [Leu(4-OH,5-NH2)7]Phalloidin | 92-1-10A | 1 mg |
| Amino-Phalloidin, [Leu(4-OH,5-NH2)7]Phalloidin | 92-1-10B | 5 mg |
| Biotin-C6-C6-Phalloidin | 92-0-19A | 1 mg |
| Biotin-C6-C6-Phalloidin | 92-0-19B | 5 mg |
| Biotin-Phalloidin | 92-0-18A | 1 mg |
| Biotin-Phalloidin | 92-0-18B | 5 mg |
| Coumarin-Phalloidin | 92-0-16A | 1 mg |
| Coumarin-Phalloidin | 92-0-16B | 5 mg |
| CR110-C6-[Lys7]Phalloidin | 92-3-12A | 1 mg |
| CR110-C6-[Lys7]Phalloidin | 92-3-12B | 5 mg |
| CR110-C6-Phalloidin | 92-0-17A | 1 mg |
| CR110-C6-Phalloidin | 92-0-17B | 5 mg |
| FITC-[Dap7]Phalloidin | 92-2-11A | 1 mg |
| FITC-[Dap7]Phalloidin | 92-2-11B | 5 mg |
| FITC-[Lys7]Phalloidin | 92-3-11A | 1 mg |
| FITC-[Lys7]Phalloidin | 92-3-11B | 5 mg |
| FITC-Phalloidin | 92-0-11A | 1 mg |
| FITC-Phalloidin | 92-0-11B | 5 mg |
| Phalloidin | 92-0-10A | 1 mg |
| Phalloidin | 92-0-10B | 5 mg |
| Sulfo-Rhodamine-Phalloidin | 92-0-15A | 1 mg |
| Sulfo-Rhodamine-Phalloidin | 92-0-15B | 5 mg |
| TRITC-[Dap7]Phalloidin | 92-2-13A | 1 mg |
| TRITC-[Dap7]Phalloidin | 92-2-13B | 5 mg |
| TRITC-[Lys7]Phalloidin | 92-3-16A | 1 mg |
| TRITC-[Lys7]Phalloidin | 92-3-16B | 5 mg |
| TRITC-Phalloidin | 92-0-14A | 1 mg |
| TRITC-Phalloidin | 92-0-14B | 5 mg |
Pituitary Adenylate Cyclase Activating Peptides (PACAP) | [Arg14,20,21, Leu16] PACAP (1-27), human, ovine, rat | 34-0-41A | 0.5 mg |
| [Arg14,20,21, Leu16] PACAP (1-27), human, ovine, rat | 34-0-41B | 1 mg |
| [Des-Gln16] PACAP (6-27), human, ovine, rat | 34-0-46A | 0.5 mg |
| [Des-Gln16] PACAP (6-27), human, ovine, rat | 34-0-46B | 1 mg |
| PACAP (1-27), human, ovine, rat | 34-0-40A | 0.5 mg |
| PACAP (1-27), human, ovine, rat | 34-0-40B | 1 mg |
| PACAP (1-38), human, ovine, rat | 34-0-20A | 0.5 mg |
| PACAP (1-38), human, ovine, rat | 34-0-20B | 1 mg |
| PACAP (6-27), human, ovine, rat | 34-0-45A | 0.5 mg |
| PACAP (6-27), human, ovine, rat | 34-0-45B | 1 mg |
| PACAP (6-38), human, ovine, rat | 34-0-19A | 0.5 mg |
| PACAP (6-38), human, ovine, rat | 34-0-19B | 1 mg |
| PACAP-38 (16-38), human, ovine, rat | 34-0-23A | 0.5 mg |
| PACAP-38 (16-38), human, ovine, rat | 34-0-23B | 1 mg |
| PACAP-Related Peptide (PRP), rat | 34-0-52A | 0.5 mg |
| PACAP-Related Peptide (PRP), rat | 34-0-52B | 1 mg |
Prolactin Releasing Peptide | Prolactin-Releasing Peptide (1-31), rat | 52-6-12A | 0.5 mg |
| Prolactin-Releasing Peptide (1-31), rat | 52-6-12B | 1 mg |
Protease Inhibitor | Acetyl-Pepstatin | 84-0-01A | 1 mg |
| Acetyl-Pepstatin | 84-0-01B | 5 mg |
| (Z-LL)2 Ketone | 84-0-00 | 5 mg |
Protein Kinase and Related Peptides | [Ala9,10, Lys11,12] Glycogen Synthase (1-12) | 86-0-41A | 1 mg |
| [Ala9,10, Lys11,12] Glycogen Synthase (1-12) | 86-0-41B | 5 mg |
| [Ala9] Autocamtide 2 | 86-5-10A | 0.5 mg |
| [Ala9] Autocamtide 2 | 86-5-10B | 1 mg |
| [His5] Autocamtide 2 | 86-5-11A | 0.5 mg |
| [His5] Autocamtide 2 | 86-5-11B | 1 mg |
| [pGlu4]-Myelin Basic Protein 4-14 | 86-2-40A | 0.5 mg |
| [pGlu4]-Myelin Basic Protein 4-14 | 86-2-40B | 1 mg |
| [Ser25] Protein Kinase C (19-31) | 86-0-33A | 0.5 mg |
| [Ser25] Protein Kinase C (19-31) | 86-0-33B | 1 mg |
| Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 86-2-31A | 0.5 mg |
| Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 86-2-31B | 1 mg |
| Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 86-2-32A | 0.5 mg |
| Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 86-2-32B | 1 mg |
| Achatin-1 | 86-5-15A | 0.5 mg |
| Achatin-1 | 86-5-15B | 1 mg |
| Ac-MBP (4-14) Peptide | 86-2-45A | 0.5 mg |
| Ac-MBP (4-14) Peptide | 86-2-45B | 1 mg |
| Arg-Gly-Tyr-Ala-Leu-Gly | 86-0-52A | 1 mg |
| Arg-Gly-Tyr-Ala-Leu-Gly | 86-0-52B | 5 mg |
| Arg-Lys-Arg-Ala-Arg-Lys-Glu | 86-0-56A | 1 mg |
| Arg-Lys-Arg-Ala-Arg-Lys-Glu | 86-0-56B | 5 mg |
| Arg-Lys-Arg-Ser-Arg-Ala-Glu | 86-0-59A | 1 mg |
| Arg-Lys-Arg-Ser-Arg-Ala-Glu | 86-0-59B | 5 mg |
| Arg-Lys-Arg-Ser-Arg-Lys-Glu | 86-0-55A | 1 mg |
| Arg-Lys-Arg-Ser-Arg-Lys-Glu | 86-0-55B | 5 mg |
| Asp371, Tyrosinase (369-377), human | 86-3-13 | 1 mg |
| Autocamtide 2 | 86-0-40A | 0.5 mg |
| Autocamtide 2 | 86-0-40B | 1 mg |
| Calcineurin Autoinhibitory Peptide | 22-2-15A | 0.5 mg |
| Calcineurin Autoinhibitory Peptide | 22-2-15B | 1 mg |
| Calmodulin Dependent Protein Kinase II (290-309) | 73-0-45A | 0.5 mg |
| Calmodulin Dependent Protein Kinase II (290-309) | 73-0-45B | 1 mg |
| Calmodulin Dependent Protein Kinase Substrate | 86-2-55A | 1 mg |
| Calmodulin Dependent Protein Kinase Substrate | 86-2-55B | 5 mg |
| cAMP Dependent PK Inhibitor (5-24) | 86-1-45A | 0.5 mg |
| cAMP Dependent PK Inhibitor (5-24) | 86-1-45B | 1 mg |
| cAMP Dependent PK Inhibitor, PKI (14-24), amide | 86-1-55A | 0.5 mg |
| cAMP Dependent PK Inhibitor, PKI (14-24), amide | 86-1-55B | 1 mg |
| Casein Kinase II Substrate | 86-2-25A | 0.5 mg |
| Casein Kinase II Substrate | 86-2-25B | 1 mg |
| Cys-Kemptide | 86-0-49A | 1 mg |
| Cys-Kemptide | 86-0-49B | 5 mg |
| EGF-R (661-681) T669 Peptide | 86-5-35A | 1 mg |
| EGF-R (661-681) T669 Peptide | 86-5-35B | 5 mg |
| Kemptamide | 86-0-54A | 1 mg |
| Kemptamide | 86-0-54B | 5 mg |
| Kemptide | 86-0-50A | 1 mg |
| Kemptide | 86-0-50B | 5 mg |
| Kemptide, amide | 86-0-58A | 1 mg |
| Kemptide, amide | 86-0-58B | 5 mg |
| K-R-T-L-R-R | 86-2-50 | 1 mg |
| Malantide | 86-0-42A | 0.5 mg |
| Malantide | 86-0-42B | 1 mg |
| Melittin | 86-4-10A | 0.5 mg |
| Melittin | 86-4-10B | 1 mg |
| Melittin, Free Acid | 86-4-11A | 0.5 mg |
| Melittin, Free Acid | 86-4-11B | 1 mg |
| Myosin Kinase Inhibiting Peptide | 79-2-40A | 1 mg |
| Myosin Kinase Inhibiting Peptide | 79-2-40B | 5 mg |
| P34cdc2 Kinase Fragment | 86-5-25A | 1 mg |
| P34cdc2 Kinase Fragment | 86-5-25B | 5 mg |
| P34cdc2 Peptide (PSTAIR) | 86-5-30A | 0.5 mg |
| P34cdc2 Peptide (PSTAIR) | 86-5-30B | 1 mg |
| P60c-src Substrate II | 86-2-33A | 0.5 mg |
| P60c-src Substrate II | 86-2-33B | 1 mg |
| P60c-src Substrate II, Phosphorylated | 86-2-34A | 0.5 mg |
| P60c-src Substrate II, Phosphorylated | 86-2-34B | 1 mg |
| pp60 c-src (521-533) | 86-3-11 | 1 mg |
| Protein Kinase A Inhibitor (6-22), amide | 86-0-20A | 0.5 mg |
| Protein Kinase A Inhibitor (6-22), amide | 86-0-20B | 1 mg |
| Protein Kinase C (19-36) Peptide | 86-1-25A | 0.5 mg |
| Protein Kinase C (19-36) Peptide | 86-1-25B | 1 mg |
| Protein Kinase C Substrate | 86-2-30A | 1 mg |
| Protein Kinase C Substrate | 86-2-30B | 5 mg |
| Protein Kinase Cδ Peptide Substrate | 86-1-17A | 0.5 mg |
| Protein Kinase Cδ Peptide Substrate | 86-1-17B | 1 mg |
| Protein Kinase Cε Peptide Substrate | 86-1-18A | 0.5 mg |
| Protein Kinase Cε Peptide Substrate | 86-1-18B | 1 mg |
| Protein Kinase Cε Translocation Inhibitor Peptide, Negative Control | 86-1-16A | 0.5 mg |
| Protein Kinase Cε Translocation Inhibitor Peptide, Negative Control | 86-1-16B | 1 mg |
| QKRPSQRSKYL | 86-0-21A | 0.5 mg |
| QKRPSQRSKYL | 86-0-21B | 1 mg |
| RREEETEEE | 86-2-26A | 0.5 mg |
| RREEETEEE | 86-2-26B | 1 mg |
| RRKASGP | 86-0-11A | 1 mg |
| RRKASGP | 86-0-11B | 5 mg |
| RRRDDDSDDD | 86-2-27A | 0.5 mg |
| RRRDDDSDDD | 86-2-27B | 1 mg |
| S6 Kinase Substrate Peptide 32 | 86-0-13A | 0.5 mg |
| S6 Kinase Substrate Peptide 32 | 86-0-13B | 1 mg |
| S6-1 | 86-2-35A | 1 mg |
| S6-1 | 86-2-35B | 5 mg |
| Substrate for Tyrosine Protein Kinase | 86-0-10A | 0.5 mg |
| Substrate for Tyrosine Protein Kinase | 86-0-10B | 1 mg |
| Syntide 2 | 86-0-30A | 0.5 mg |
| Syntide 2 | 86-0-30B | 1 mg |
| Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | 86-3-12 | 1 mg |
| Tyrosinase (192-200), human mouse | 81-0-17A | 0.5 mg |
| Tyrosinase (192-200), human mouse | 81-0-17B | 1 mg |
| Tyrosinase (206-214), human | 81-0-18A | 0.5 mg |
| Tyrosinase (206-214), human | 81-0-18B | 1 mg |
| Woodtide | 86-2-37A | 0.5 mg |
| Woodtide | 86-2-37B | 1 mg |
| Woodtide, FAM-labeled, Forkhead derived peptide | 86-2-38 | 1 mg |
Quick Label¢â Biotinylation Reagents | Biotin-C6-OH | QLB-REAG101 | 1 g |
| Biotin-C6-OSu | QLB-REAG102 | 1 g |
| Biotin-Dah | QLB-REAG110 | 50 mg |
| Biotin-Dah-iodoacetyl | QLB-REAG105 | 50 mg |
| Biotin-OSu | QLB-REAG100 | 1 g |
| Biotin-PEG2-Iodoacetyl | QLB-REAG107 | 50 mg |
| Biotin-PEG2-Maleimide | QLB-REAG109 | 50 mg |
| Biotin-PEG2-NH2 | QLB-REAG112 | 50 mg |
| Biotin-PEG3-Maleimide | QLB-REAG108 | 50 mg |
| Fmoc-Lys(Biotin)-OH | QLB-REAG115 | 1 g |
| Fmoc-Lys(C6-Biotin)-OH | QLB-REAG113 | 1 g |
| Fmoc-Lys(PEG3-Biotin)-OH | QLB-REAG114 | 1 g |
Renin Substrates & Inhibitors | [Cys8] Renin Substrate Tetradecapeptide, rat | 12-2-20A | 1 mg |
| [Cys8] Renin Substrate Tetradecapeptide, rat | 12-2-20B | 5 mg |
| [Leu8] Renin Substrate Tetradecapeptide, rat | 12-2-30A | 1 mg |
| [Leu8] Renin Substrate Tetradecapeptide, rat | 12-2-30B | 5 mg |
| [Val8] Renin Substrate Tetradecapeptide, rat | 12-2-40A | 1 mg |
| [Val8] Renin Substrate Tetradecapeptide, rat | 12-2-40B | 5 mg |
| Acetyl Angiotensinogen (1-14), porcine | 12-4-10A | 1 mg |
| Acetyl Angiotensinogen (1-14), porcine | 12-4-10B | 5 mg |
| Acetyl, Angiotensinogen (1-14), human | 12-1-79A | 1 mg |
| Acetyl, Angiotensinogen (1-14), human | 12-1-79B | 5 mg |
| Angiotensinogen (1-13), human | 12-1-71A | 1 mg |
| Angiotensinogen (1-13), human | 12-1-71B | 5 mg |
| Angiotensinogen (1-14), human | 12-1-77A | 1 mg |
| Angiotensinogen (1-14), human | 12-1-77B | 5 mg |
| Angiotensinogen (1-14), porcine | 12-1-67A | 1 mg |
| Angiotensinogen (1-14), porcine | 12-1-67B | 5 mg |
| P-H-P-F-H-F-F-V-Y-K | 12-1-70A | 1 mg |
| P-H-P-F-H-F-F-V-Y-K | 12-1-70B | 5 mg |
| Renin Inhibitor Peptide | 12-1-72A | 1 mg |
| Renin Inhibitor Peptide | 12-1-72B | 5 mg |
| Renin Substrate 1 | 12-2-11A | 1 mg |
| Renin Substrate 1 | 12-2-11B | 5 mg |
| Renin Substrate Tetradecapeptide, rat | 12-2-10A | 1 mg |
| Renin Substrate Tetradecapeptide, rat | 12-2-10B | 5 mg |
Sarafotoxins | [Lys4] Sarafotoxin S6c | 88-9-30A | 0.5 mg |
| [Lys4] Sarafotoxin S6c | 88-9-30B | 1 mg |
| Sarafotoxin S6a | 88-9-20A | 0.5 mg |
| Sarafotoxin S6a | 88-9-20B | 1 mg |
| Sarafotoxin S6b | 88-9-10A | 0.5 mg |
| Sarafotoxin S6b | 88-9-10B | 1 mg |
| Sarafotoxin S6c | 88-9-35A | 0.5 mg |
| Sarafotoxin S6c | 88-9-35B | 1 mg |
| Sarafotoxin S6d | 88-9-40A | 0.5 mg |
| Sarafotoxin S6d | 88-9-40B | 1 mg |
Secretins | Secretin, human | 46-1-75 | 1 mg |
| Secretin, porcine | 46-1-77A | 0.5 mg |
| Secretin, porcine | 46-1-77B | 1 mg |
| Secretin, rat | 46-1-76A | 0.5 mg |
| Secretin, rat | 46-1-76B | 1 mg |
Somatostatins & Analogs | (Ac-Nle4, Asp5, DPhe7, Lys10)-Cyclo-a-MSH (4-10) amide, MTII | 68-1-30A | 1 mg |
| (Ac-Nle4, Asp5, DPhe7, Lys10)-Cyclo-a-MSH (4-10) amide, MTII | 68-1-30B | 5 mg |
| [Des-Ala1,Des-Gly2,His4,5,DTrp8] Somatostatin | 68-1-41 | 1 mg |
| [DTrp8,DCys14] Somatostatin | 68-1-33 | 1 mg |
| [DTrp8,Tyr11] Somatostatin | 68-1-37 | 1 mg |
| [DTrp8] Somatostatin | 68-1-22 | 1 mg |
| [Leu8,DTrp22,Tyr25] Somatostatin (1-28) | 68-1-57A | 0.5 mg |
| [Leu8,DTrp22,Tyr25] Somatostatin (1-28) | 68-1-57B | 1 mg |
| [Nle8] Somatostatin (1-28) | 68-1-54A | 0.5 mg |
| [Nle8] Somatostatin (1-28) | 68-1-54B | 1 mg |
| [Tyr0,DTrp8] Somatostatin | 68-1-25 | 1 mg |
| [Tyr0] Somatostatin | 68-1-20 | 1 mg |
| [Tyr0] Somatostatin (1-28) | 68-1-52A | 0.5 mg |
| [Tyr0] Somatostatin (1-28) | 68-1-52B | 1 mg |
| [Tyr1] Somatostatin | 68-1-17 | 1 mg |
| [Tyr11] Somatostatin | 68-1-14 | 1 mg |
| [Tyr12] Somatostatin 28 (1-14) | 68-1-44 | 1 mg |
| BIM-23027 | 68-1-69A | 0.5 mg |
| BIM-23027 | 68-1-69B | 1 mg |
| CTAP | 68-1-70A | 0.5 mg |
| CTAP | 68-1-70B | 1 mg |
| DNal-Cys-Tyr-DTrp-Lys-Val-Cys-Nal-NH2 | 68-1-64A | 1 mg |
| DNal-Cys-Tyr-DTrp-Lys-Val-Cys-Nal-NH2 | 68-1-64B | 5 mg |
| DOTA-[Tyr3] - Octreotide | 68-1-42 | 1 mg |
| DOTA-[Tyr3] - Octreotide Acid (Octreotate) | 68-1-43 | 1 mg |
| NTB (Naltriben) | 68-1-65A | 0.5 mg |
| NTB (Naltriben) | 68-1-65B | 1 mg |
| Octreotide (SMS 201-995) | 68-1-47A | 0.5 mg |
| Octreotide (SMS 201-995) | 68-1-47B | 1 mg |
| Prosomatostatin (1-32), porcine | 68-1-68A | 0.5 mg |
| Prosomatostatin (1-32), porcine | 68-1-68B | 1 mg |
| RC-160 (Vapreotide) | 68-1-71A | 0.5 mg |
| RC-160 (Vapreotide) | 68-1-71B | 1 mg |
| RC-160 [Lys(Boc)] | 68-1-49A | 0.5 mg |
| RC-160 [Lys(Boc)] | 68-1-49B | 1 mg |
| Somatostatin 14 | 68-1-10 | 5 mg |
| Somatostatin 28 | 68-1-50A | 0.5 mg |
| Somatostatin 28 | 68-1-50B | 1 mg |
| Somatostatin 28 (1-14) | 68-1-60 | 1 mg |
| Somatostatin Antagonist | 68-1-48 | 1 mg |
| Somatostatin Tumor Inhibiting Analog | 68-1-45 | 1 mg |
Stresscopin Related Peptides | Stresscopin, human | 68-2-00A | 0.5 mg |
| Stresscopin, human | 68-2-00B | 1 mg |
| Stresscopin-Related Peptide, human | 68-2-01A | 0.5 mg |
| Stresscopin-Related Peptide, human | 68-2-01B | 1 mg |
Substance P & Related Peptides | [Arg3] Substance P | 70-1-32 | 1 mg |
| [DArg1, DTrp5,7,9, Leu11] Substance P | 70-9-19A | 1 mg |
| [DArg1, DTrp5,7,9, Leu11] Substance P | 70-9-19B | 5 mg |
| [DArg1,DPhe5,DTrp7,9,Leu11] Substance P | 70-9-18A | 1 mg |
| [DArg1,DPhe5,DTrp7,9,Leu11] Substance P | 70-9-18B | 5 mg |
| [DArg1,DPro2,DTrp7,9,Leu11] Substance P | 70-1-90 | 1 mg |
| [DArg1,DTrp7,9,Leu11] Substance P | 70-1-88 | 1 mg |
| [DPro2,DPhe7,DTrp9] Substance P | 70-1-92 | 1 mg |
| [DPro2,DTrp7,9] Substance P | 70-9-23 | 1 mg |
| [DPro4,DTrp7,9,Nle11] Substance P (4-11) | 70-9-27A | 0.5 mg |
| [DPro4,DTrp7,9,Nle11] Substance P (4-11) | 70-9-27B | 1 mg |
| [DPro4,DTrp7,9] Substance P (4-11) | 70-9-26 | 1 mg |
| [Glp5,(Me)Phe8,Sar9] Substance P (5-11) | 70-1-62 | 1 mg |
| [Glp5,Sar9] Substance P (5-11) | 70-1-64 | 1 mg |
| [Glp5] Substance P (5-11) | 70-1-54 | 1 mg |
| [Glp6,Pro9] Substance P (6-11)/Septide | 70-9-15A | 1 mg |
| [Glp6,Pro9] Substance P (6-11)/Septide | 70-9-15B | 5 mg |
| [Glp6] Substance P (6-11) | 70-1-70 | 1 mg |
| [Nle11] Substance P | 70-1-21 | 1 mg |
| [Pro9] Substance P | 70-1-31A | 0.5 mg |
| [Pro9] Substance P | 70-1-31B | 1 mg |
| [Sar9, Met(O2)11] Substance P | 70-1-22 | 5 mg |
| [Succinyl-Asp6,Me-Phe8] Substance P | 70-1-99A | 1 mg |
| [Succinyl-Asp6,Me-Phe8] Substance P | 70-1-99B | 5 mg |
| [Tyr8] Substance P | 70-1-18 | 1 mg |
| Antagonist G | 70-9-32A | 0.5 mg |
| Antagonist G | 70-9-32B | 1 mg |
| Scyliorhinin I, amide, dogfish | 62-7-70 | 1 mg |
| Scyliorhinin II, amide, dogfish | 62-7-72A | 0.5 mg |
| Scyliorhinin II, amide, dogfish | 62-7-72B | 1 mg |
| Spantide II | 70-1-87A | 0.5 mg |
| Spantide II | 70-1-87B | 1 mg |
| Substance P | 70-1-10 | 5 mg |
| Substance P (1-4) | 70-1-85 | 1 mg |
| Substance P (1-7) | 70-1-83 | 1 mg |
| Substance P (1-9) | 70-1-80 | 1 mg |
| Substance P (2-11)/Deca-Substance P | 70-1-40 | 1 mg |
| Substance P (3-11)/Nona-Substance P | 70-1-43 | 1 mg |
| Substance P (4-11)/Octa-Substance P | 70-1-46 | 1 mg |
| Substance P (5-11)/Hepta-Substance P | 70-1-51 | 1 mg |
| Substance P (6-11)/Hexa-Substance P | 70-1-67 | 1 mg |
| Substance P (7-11) | 70-1-73 | 1 mg |
| Substance P (9-11) | 70-1-78 | 1 mg |
| Substance P Methyl ester | 70-1-27 | 1 mg |
| Substance P reversed sequence | 70-1-11 | 5 mg |
| Substance P reversed sequence | 70-1-11A | 5 mg |
| Substance P, Free Acid | 70-1-13 | 5 mg |
| Substance P-Gly-Lys-Arg | 70-1-38 | 1 mg |
Substrate & Enzyme Inhibitors | 7-Methoxycoumarin-4-Acetyl-Pro-Leu-Gly-Leu-Dnp-(2,3-Diaminopropionyl)-Ala-Arg, amide | |